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ABSTRACT 
 
Bovine herpesvirus-1 (BHV-1) is prevalent globally and is an important cause of bovine disease. 
Humoral and cell-mediated immune responses contribute to viral clearance following a primary 
BHV-1 respiratory infection but innate immune mechanisms contributing to early control of 
BHV-1 infection are not known. Gene expression analyses and immunohistochemical (IHC) 
studies were used to investigate the role of interferons (IFNs) and innate immune cells during a 
primary BHV-1 infection. There was significant (P < 0.05) induction of type I IFN and IFN-
stimulated genes (ISGs) in the URT within 3 days post-infection (pi) but virus shedding 
continued for another 4 to 7 days. In vitro studies demonstrated that both type I and II IFNs had 
limited capacity to inhibit BHV-1 replication and BHV-1 infection did not block ISG 
transcription. Consequently, immune cell recruitment to the URT was analyzed following BHV-
1 infection to determine if alternative defence mechanisms were activated. Morphometric 
analyses of lymphocytes in URT tissues before and after BHV-1 infection revealed significant (P 
< 0.05) increases in cell populations expressing CD335+ (NKp46 natural cytotoxicity receptor), 
CD3+ (T-cell lineage marker) and CD8+ (cytotoxic T-cell marker) on day 5 pi. Confocal 
microscopy confirmed that approximately 90% of lymphocytes present on day 5 pi were T-cells 
co-expressing CD335 and CD8. This bovine T-cell subpopulation is known as non-conventional 
T cells, which may be innate lymphocytes. Specific recruitment of non-conventional T-cells to 
the site of BHV-1 infection in the URT raised questions regarding what chemokines may be 
involved in regulating this selective cell migration. Chemokine(s) involved in non-conventional 
T-cell recruitment in cattle are currently not known. qRT-PCR analysis of known bovine 
chemokine genes revealed that the expression of CCL4, CCL5 and CXCL9 genes were 
significantly (P < 0.05) up-regulated following BHV-1 infection in nasal turbinates. Thus, one or 
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more of these chemokines may be involved in the selective recruitment of bovine non-
conventional T-cells to the site of BHV-1 infection. The specific recruitment of non-
conventional T cells to infected tissue suggests these cells may play an important role in either 
viral clearance or regulating host responses during BHV-1 infection.   
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CHAPTER 1: INTRODUCTION AND LITERATURE REVIEW 
 
1.1 THE MUCOSAL IMMUNE SYSTEM IN THE UPPER RESPIRATORY TRACT 
OF CALVES 
A modified version of Section 1.1 has been published online in Annual Reviews of Bioscience as 
Osman, R; Malmuthuge, N, Gonzalez-Cano, P and Griebel, P. Development and Function of the 
Mucosal Immune System in the Upper Respiratory Tract of Neonatal Calves .Annual Review of 
Animal Biosciences 2018 6:1 
I wrote all sections of the manuscript included in my thesis with editing by Dr. PJ Griebel. 
 
 
1.1.1 ABSTRACT 
 
Respiratory infections remain the second most common cause of clinical disease and 
mortality in young calves, which has led to increased interest in using vaccines early in life 
to mitigate this risk. Intranasal (IN) vaccination of neonatal calves can be an effective 
strategy to circumvent vaccine interference by maternal antibody but this raises questions 
regarding onset of immune competence in the upper respiratory tract (URT) following 
birth. Little is known, however, about the development and function of mucosal-associated 
lymphoid tissue (MALT) in the URT of young calves and what factors, including the 
commensal microbiome, contribute to this early development. We review the structure, 
development, and function of MALT in the bovine URT during the first six weeks of life 
and identify knowledge gaps regarding this early development. This information is critical 
when designing vaccination programs for young calves, especially when targeting 
respiratory pathogens that may reside within the commensal microbiome. 
 
1.1.2 INTRODUCTION 
 
The upper respiratory tract (URT) is a point of entry for many pathogens that cause either 
respiratory or enteric infections. The URT consists of nostrils, nasal turbinates, the 
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nasopharyngeal tonsil, the retropharyngeal lymph node, and the pharynx (Figure 1.1). It is 
also an important route of transmission for pathogens that are shed in oral or nasal 
secretions. The URT is covered by mucosal epithelium that provides an interface between 
the host and the diverse bacterial and viral populations, which constitute both “resident” 
microbiota and potential pathogens. Resident microbiota refers to microorganisms, which 
persist over prolonged periods in close association with the mucosal epithelium of the 
URT. In contrast, the transitory microbiota includes microorganisms that are either inhaled 
or ingested but persist for a brief time in the URT [1]. The mucosal surface forms the 
host’s physical and immunological barrier to resident and transitory microbiota and 
potential pathogens. Maintenance of this barrier is critical to the health of an animal and a 
variety of innate and acquired immune responses contribute to barrier maintenance. Rapid 
development of this barrier is crucial as the newborn calf emerges from the sterile uterine 
environment to an environment populated with microorganisms.  
 
1.1.3 INNATE IMMUNE RESPONSES  
 
Mucosal surfaces in the URT provide protective physical and immunological barriers 
against pathogens and toxic substances in the environment. The local innate immune 
system is comprised of the mucosal epithelium, mucins, pattern-recognition receptors 
(PRRs), antimicrobial peptides, and a variety of effector cells.  
 
1.1.3.1 Physical barriers 
 
The first barrier to pathogens and large particulate matter in the bovine URT is hair, which 
filters large airborne material as it enters the nasal cavity [2]. The next physical barrier is 
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the pseudostratified columnar mucosal epithelium on the surface of the nasal conchae.  The 
epithelial barrier involves tight junctions with lateral cell-to-cell contact to prevent 
invasion by pathogens or resident microbiota. The mucosal epithelium also includes 
specialized cells such as ciliated epithelial cells and goblet cells. Goblet cells produce 
mucus and ciliated epithelial cells are involved in mucus clearance. Mucus is a viscous 
fluid, which covers mucosal surfaces. It forms a thick layer on the mucosal epithelial 
surface and traps foreign substances and microbial pathogens that are inhaled. This trapped 
material is then cleared through mucociliary clearance. The composition of mucus in the 
bovine URT has not yet been characterized. In humans, however, it is primarily composed 
of a complex mix of polysaccharides, including mucins (MUC) [3], with MUC2 and 
MUC3 being the most abundant. MUC 1, 4 and 16 are membrane bound while MUC2, 
5AC, 5B and 19 are secreted into the human respiratory tract [4]. Although mucus has a 
protective role at mucosal surfaces, unregulated or poorly regulated mucin production is 
associated with diseases such as cystic fibrosis and chronic obstructive pulmonary disease 
(COPD) [3]. The production of mucins in the URT of newborn calves has not been 
investigated and it is not known at what age this defence mechanism is fully functional or 
what factors may delay or disrupt mucin production during this vulnerable period. 
 
1.1.3.2 Pattern Recognition Receptors  
 
If pathogens or other noxious substances breach the physical barrier of the mucosal 
epithelium, it is important that the host is able to sense this danger. Pattern recognition 
receptors (PRR) are expressed by mammalian mucosal epithelium and immune 
surveillance cells including dendritic cells (DCs), macrophages and neutrophils.  These 
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PRRs include several families of molecules, such as Toll-like receptors (TLRs), NOD-like 
receptors (NLRs) and retinoic acid-inducible gene-I (RIG-I). PRRs recognize pathogen-
associated molecular patterns (PAMPs) of pathogens or commensal microbiota or danger 
associated molecular patterns (DAMPs) released during tissue damage.  Although the 
expression of PRRs in the bovine URT has not been analyzed, it has been reported that the 
bovine TLR 1 through 10 genes are expressed in  the tracheal mucosa [5]. It is not known, 
however, whether the expression of PRRs varies among regions of the URT, oral cavity, or 
the lung. Further work is also required to determine which PRRs are expressed by the 
mucosal epithelium and resident immune cells in the mucosa and submucosa of the URT. 
PRRs play an important role in not only recognizing invading pathogens but also provide 
signals that regulate the induction of the acquired immune responses to vaccines. 
Determining if there are significant regional and age-dependent differences in the 
expression of PRRs in the bovine URT may inform the formulation and delivery of 
intranasal (IN) vaccines in young calves. 
 
1.1.3.3 Antimicrobial peptides 
 
Another component of the innate immune defence provided by the mucosal epithelium is 
the production of host defence peptides, also known as antimicrobial peptides. These small 
peptides have many functions, including cytotoxic effects on bacteria and viruses, anti-
inflammatory activity, stimulation of epithelial cell growth, tissue damage repair, and 
immune cell activation and recruitment. These secreted peptides are often retained within 
the mucus layer. In sheep, antimicrobial anionic peptide (AP) is produced by alveolar 
epithelium and has been shown to bind to and inactivate Mannheimia haemolytica  [6]. In 
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cattle, a number of beta-defensins have been identified in the respiratory tract. Tracheal 
antimicrobial peptide (TAP) was the first bovine beta-defensin discovered in bovine 
tracheal mucosa and shown to have antimicrobial activity against Gram-positive and 
negative bacteria. Lingual (tongue) antimicrobial peptide (LAP) was the second beta-
defensin discovered and is expressed in bovine nasal, buccal, conjunctival and tracheal 
mucosa. The same study showed that LAP expression is present in young and adult calves 
but absent in fetal tongue, suggesting exposure to microbes may contribute to antimicrobial 
peptide expression [7]. Another bovine beta-defensin, DEFB103 was shown to be highly 
expressed in epithelial cells located in the oral cavity, and tracheal epithelium of young 
calves. The level of DEFB103 expression in neonatal calves was similar to that observed in 
older calves [8]. Additionally, DEFB103 expression was up-regulated in the oral 
epithelium of 6 to 8 months old calves following an URT infection by bovine herpesvirus-
1 (BHV-1). Further studies are required to fully characterize the range of host defence 
peptides expressed throughout the bovine URT and better define the many roles they may 
play in regulating microbial infections [8]. 
 
1.1.3.4 Effector cells 
 
Innate immune effector cells in the bovine respiratory tract include phagocytic dendritic 
cells (DCs), macrophages, natural killer (NK) cells and granulocytes [2, 9]. It has been 
shown that the abundance of bovine NK cells and neutrophils increases in blood during the 
first 3 months of life [10]. Studies of bovine mucosal tissues in the gut have shown that 
macrophages and DCs are present in neonatal calves at 21 days of age [11]. However, the 
abundance and distribution of these cells has yet to be analyzed in the URT of young 
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calves. Thus, it is not known if there is a paucity of innate immune effector cells present at 
mucosal surfaces of the newborn URT and at what age these defences may become fully 
functional. This information is critical for understanding not only innate immune defences 
but also for understanding the capacity of mucosal immune tissues to sample foreign 
antigens and initiate the induction of an acquired immune response. 
 
1.1.4 ACQUIRED IMMUNE RESPONSES 
 
1.1.4.1 Immune Induction Sites  
 
Mucosa-associated lymphoid tissue (MALT) in the URT consists of both inductive and 
effector sites. The inductive sites consist of organized lymphoid tissues, with aggregated or 
isolated lymphoid follicles (ILF) distributed within T-cell rich regions, known as the inter-
follicular zone (IF). Specialized epithelium overlying this organized lymphoid tissue 
contains microfold (M)-cells that play a key role in antigen sampling. DCs are also 
distributed throughout the mucosal epithelium and play an important role in immune 
surveillance. Antigen taken up by DCs is then transported through the lymphatic system to 
draining lymph nodes associated with the URT.  The primary function of MALT inductive 
sites is the generation of antigen-specific, Th2-dependent immunoglobulin A (IgA) plasma 
cells.  
 
1.1.4.2 Mucosa-Associated Lymphoid Tissue (MALT) in the Bovine URT 
 
The MALT in the bovine URT includes nasal-associated lymphoid tissue (NALT) and the 
lymphoid tissues of Waldeyer’s ring, which includes the lingual, palatine, pharyngeal and 
tubal tonsils. NALT has been most extensively studied in mice and humans, with few 
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studies in domestic animals, including ruminants. Murine NALT is characterized by a pair 
of aggregated lymphoid follicles located at the base of the nasal cavity near the entry of the 
pharyngeal duct [12].  In sheep, ILFs have been shown to be distributed across the 
nasopharyngeal region and contain numerous well-developed germinal centres in the 
region of the Eustachian tube [13]. Sheep nasal lymphoid tissues are covered by ciliated 
pseudostratified columnar (epithelial) and non-ciliated M-cells [14]. Previous studies have 
also shown that the equine ILFs are distributed in 9 different locations with varying density 
within the nasal cavity [15].  Although a higher density and number of inductive sites may 
indicate a greater capacity for induction of mucosal immune responses, this hypothesis has 
not been tested. Alternatively, these ILFs may represent antigen-induced MALT as has 
been reported for bronchus-associated lymphoid tissue in the lung [16].  
 
Waldeyer’s ring consists of several aggregated lymphoid nodules known as tonsils. In 
cattle, this includes the lingual, palatine, pharyngeal, tubal tonsils and the tonsil of the soft 
palate [16]. The palatine, lingual and soft palate tonsils protect the oropharynx, while the 
pharyngeal tonsil protects the nasopharynx. The lingual tonsil consists of many 
cryptolymphatic units (CLU), which extend from the base of the tongue along the lateral 
pharynx to the epiglottis. CLU consists of epithelial crypts, which are encircled by 
lymphoid follicles and interfollicular spaces. The palatine tonsil is set in the wall of the 
oropharynx (Figure 1.1), while the tonsil of the soft palate is made up of CLUs, which are 
exposed to the oral cavity.  
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Figure 1.1 Mucosa-associated lymphoid tissue in the upper respiratory tract of a 
young calf. A midsagittal section of the head reveals organized lymphoid tissues present in the 
nasopharynx and oropharynx of a young calf. Located posterior to the nasal passages and 
protruding into the nasopharynx is the nasopharyngeal tonsil (NP T). The NP T is characterized by 
numerous rugae separated by folds. The palatine tonsil (Pal T) is located in the submucosa of the 
oropharynx lateral to the base of tongue. The Pal T is only visible as the crypt that communicates 
with the oropharynx. Inset: Mucosal epithelium overlying the retropharyngeal lymph node (Rp 
LN) was removed to reveal the Rp LN located in the submucosa adjacent to the NP T. 
 
The pharyngeal and palatine tonsils are the major components of the Waldeyer’s ring in 
cattle (Figure 1.1). The pharyngeal tonsil is first recognizable at 95 days of gestation. This 
tonsil consists of parallel “rugae”, which form a series of shallow folds and furrows with 
the number of rugae ranging from 8 to 14 by 95 days of gestation [17]. The pharyngeal 
tonsil is not fully developed at birth but rapidly develops within the first two to three weeks 
postpartum (Figure 1.2). Post-natal development of rugae is characterized by increased 
infiltration of lymphocytes into the IF region and the formation of germinal centers is 
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evident within 3 weeks after birth (Figure 1.2). The size of this lymphoid tissue then 
decreases in animals older than 7 years due to a decrease in lymphoid follicle size and 
number [17].  A morphological analysis of pharyngeal tonsils in calves has shown that the 
pharyngeal tonsilar surface is composed of reticular and non-reticular epithelial cells, 
which are a mix of ciliated and non-ciliated pseudostratified columnar epithelial cells, 
rounded microvillus-covered cells and flat squamous cells harboring lymphocytes. These 
lymphocytes include T-cells (CD4+, CD8+, γδTCR+), macrophages (CD14+), and DCs 
(CD11c+ and CD 172a+) [18]. However, the abundance and distribution of these leukocyte 
populations during pharyngeal tonsil development in newborn calves is still unknown.  
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Figure 1.2. Rapid development of nasopharyngeal tonsil occurs in newborn calves.  
(A) The nasopharyngeal tonsil in the fetal calf (day 260 gestation) is characterized by few 
epithelial crypts (Epi C), no formation of rugae at the mucosal surface (Epi), and a diffuse 
lymphoid (Lym) infiltration in the submucosa. (B) In 7-day old calves, the nasopharyngeal tonsil is 
characterized by the formation of numerous rugae (Ru) separated by epithelial crypts. There is an 
extensive accumulation of lymphocytes within each ruga. (C) The nasopharyngeal tonsil in 21-day 
old calves has increased markedly in size and located within each ruga are numerous germinal 
centres (GC).  
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Similar to the pharyngeal tonsil, the bovine palatine tonsils are not fully developed at birth 
and may require as much as 2 months to be fully developed [19]. The number of secondary 
lymphoid follicles continue to increase until adulthood when distinct germinal centers and 
IF areas are clearly visible [20].  These observations are consistent with studies in mice 
that report NALT organogenesis is dependent on exposure to environmental antigens as 
well as the presence of chemokines such as CXCL13, CCL19 and CCL21 [21]. It is not 
known, however, whether exposure to commensal bacteria or pathogens contributes to the 
rapid development of bovine tonsils  in the URT (Figure 1.2). 
 
1.1.4.3 Lymphocenters and Lymph nodes 
 
The bovine URT contains 3 lymphocenters, each consisting of multiple lymph nodes. The 
parotid lymphocenter drains the skin and anterior part of the nasal cavity. The mandibular 
lymphocenter includes the mandibular and pteryhoid lymph nodes, which also drain the 
anterior nasal cavity, the skin of the head and the oral and nasal cavities. The 
retropharyngeal lymphocenter includes the medial and lateral retropharyngeal lymph node. 
These lymph nodes drain the nasopharynx and also collect lymph from the mandibular and 
parotid lymphocenters, in addition to part of the thymus, buccal mucosa, the larynx and 
pharynx [22] 
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1.1.5  IMMUNE SYSTEM FUNCTION IN THE URT OF YOUNG CALVES 
 
The functional capacity of the mucosal immune system in URT of newborn calves has 
been a point of interest due to frequent respiratory disease and an increased interest in early 
use of intranasal (IN) vaccines. The high incidence of respiratory disease in young calves 
has been attributed, in part, to the immaturity of the neonatal mucosal immune system and 
a rapid decline in protective maternal IgA levels within 5 to 7 days after birth [23].  A Th2-
biased neonatal immune response makes newborn calves susceptible to intracellular 
pathogens like viruses. One explanation for a Th2-biased response may be a reduced 
number  and functional capacity of accessory cells like dendritic cells [24]. Another 
explanation may be maternal supression of the neonatal systemic immune system as a 
consequence of the Th2-bias that develops during pregnancy to maintain immune tolerance 
of the fetus. This Th2-bias in newborn calves can be overcome to some extent when 
parenteral vaccines are adjuvanted with immune stimulatory complexes [25]. However, an 
increasing number of IN vaccination and disease challenge studies are providing evidence 
that MALT in the URT has the  capacity to respond to foreign antigens within the first 
week of life .    
 
1.1.5.1 Mucosal immunoglobulin A (IgA) responses 
Secretory IgA (sIgA) is the primary humoral immune response at mucosal surfaces of the 
bovine URT and plays an important role in neutralizing toxins and pathogens. sIgA also 
plays an important role in maintaining the barrier that excludes the dense population of 
commensal microorganisms at the mucosal surface. Antigen sampling by DCs present in 
mucosal epithelium and M-cells overlying tonsils captures inhaled and ingested antigens. 
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These antigens are then presented to either naive B-cells in the germinal centers where 
class switching to IgA can take place or DCs present processed antigens to naïve T-
lymphocytes to support the generation of Th2-dependent IgA response [26]. 
 
Human infants are highly susceptible to infections in the first year of life [27] despite the 
protection provided by maternal antibody during this time. In the newborn calf, colostrum 
is the major source of passive immunity through the transfer of primarily IgG1 antibody 
but colostrum also includes minor amounts of IgM, IgA and IgG2. The level of maternal 
antibody in bovine milk decreases significantly within a few days of birth [23, 27]. Thus, 
the immaturity of the mucosal immune system makes newborn calves vulnerable to a 
variety of respiratory infections as the level of maternal IgA is rapidly depleted within the 
first week of life (23). Neonatal mucosal immunization strategies are now being explored 
as a strategy to rapidly increase immune protection during the neonatal period [23, 28]. 
High levels of maternal antibody circulating in the blood of newborn calves have, however, 
been reported to interfere with both killed and modified-live vaccines following parenteral 
injection [29]. Mucosal immunization targeting the URT may provide an effective strategy 
to circumvent vaccine interference by maternal antibody due to a rapid depletion of 
maternal IgA in mucosal secretions in the first week after birth [23].   
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1.2 PRIMARY BOVINE HERPESVIRUS-1 INFECTION 
 
1.2.1 BOVINE HERPESVIRUS -1 
 
1.2.1.1 Herpesviruses: General Features 
 
Herpesviridae is a family of large, double-stranded DNA viruses, with a wide range of 
hosts including mammals, birds, fish and reptiles [30]. Viruses were included in this family 
based on their unique virion architecture until the 1980s [30]. The virus structure consists 
of a core with a tightly packaged genomic DNA in an icosahedral capsid. The core is 
surrounded by a protein-rich matrix, known as tegument, and enclosed in a host-cell 
derived, lipid bilayer envelope, which anchors glycoproteins [31]. Although there is 
significant diversity among herpesviruses, all members of this family cause latent 
infections in neurons following a lytic infection and recrudesce periodically. 
 
1.2.1.2 Herpesviridae Classification 
Herpesviridae are further clustered based on biological properties into 3 subfamilies: 
alpha- beta- and gamma-herpresvirinae. The biological criteria consider host range, length 
of replication cycle, cytopathology and latency-related characteristics [32]. 
Alphaherpresvirinae includes herpesviruses with a broad host range and a short replication 
cycle in mucosal epithelial cells. Following a primary infection in epithelial cells, 
alphaherpesviruses establish latent infections primarily in host sensory nerves, such as the 
trigeminal ganglia [33]. Some of the well-documented members of this group include 
human herpesviruses, such as HSV-1 and Varicella zoster virus (VZV), porcine 
herpesviruses like Pseudorabies virus (PRV), equine herpesviruses including Equine 
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herpesvirus -1 (EHV-1), and ruminant herpesviruses such as bovine herpesvirus (BHV-1).  
Betaherpesvirinae include species-specific herpesviruses with long replication cycle 
resulting in enlarged infected cells followed by lysis and latent infections in secretory 
glands, macrophages and kidneys [31] Bovine and human cytomegalovirus (CMV) are 
examples of betaherpesviruses. Gammaherpesviruses, similar to betaherpesviruses, have a 
restricted host range and cause lytic infections in lymphocytes and macrophages and 
ultimately establish latent infections in lymphocytes [31]. Examples of 
gammaherpesviruses are Epstein-Barr Virus (EBV) in humans and Bovine herpesvirus–4 
(BHV-4) in cattle [34].  
 
1.2.1.3 BHV-1: Introduction 
BHV-1 is a ruminant alphaherpesvirus, which is closely related to the human herpesvirus, 
HSV-1.  Similar to other herpesviruses, BHV-1 is composed of double-stranded, linear 
genomic DNA tightly packaged in an approximately 100 nm icosahedral capsid, 
surrounded by a tegument, and enclosed in a lipid envelope anchoring viral glycoproteins. 
 
1.2.1.4 Virus Structure 
1.2.1.4.1 Genome 
BHV-1 was first reported in 1953 in the US [35] and subsequently reported in 1958 in 
Ontario, Canada. BHV-1 infection in dairy herds was associated with sudden onset of 
severe inflammation in the upper respiratory tract  (URT) and trachea and a rapid reduction 
in milk production [36].  The virus was isolated in 1956 [35], viral proteins were first 
identified and analyzed in 1983 [37], and the genome was sequenced in 1996 [38]. BHV-1 
has a 135.3 kbp genome arranged as a Class D genome, which has two unique sequences: 
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unique long (UL) and unique short (US). BHV-1 strains have been categorized, based on 
differences in genomic sequence, into BHV-1.1, 1.2a, and 1.2b subtypes ([37, 39]. The 
BHV-1 genome encodes for 73 proteins which have been classified on the basis of 
temporal regulation into Immediate Early (IE), Early (E) and Late (L) genes [40]. The 
BHV-1 genome  also encodes 10 microRNA genes [41].  The IE proteins of BHV-1 are 
bovine infected cell protein (bICP)-0, bICP4, bICP22, and bICP27. These genes are named 
according to their homologues in HSV-1. IE genes are transcribed prior to DNA replication 
and do not require do novo viral protein synthesis for expression. IE gene expression is 
activated by a BHV-1 tegument protein, VP16, also known as α−trans-inducing factor (α-
TIF), which forms a complex with host proteins HCF-1 and Oct-1 and binds to the 
promoter of bICP0 to initiate IE transcription [42].  Early genes code for DNA-binding 
proteins and enzymes involved in DNA replication [43]. Viral DNA replication is 
catalyzed by host RNA polymerase II. Late genes encode BHV-1 structural proteins 
contributing to formation of the capsid, tegument and glycoproteins.  
 
1.2.1.4.2 Capsid 
There is limited direct information regarding the structure of the BHV-1 capsid. The 
closely related alphaherpesvirus, HSV-1, has an icosahedral capsid with symmetry of T=16 
composed of 162 capsomeres. The capsid is composed of two layers: the outer and 
intermediate layers, with the outer layer composed of four proteins [43]: VP5, VP19c, 
VP23, and VP26, in addition to proteins coded by UL6 and UL25 [44].  VP5 is the major 
capsid protein, which is conserved among alphaherpesviruses [45, 46].  
 
! 18!
1.2.1.4.3 Tegument 
The tegument is a protein-rich, amorphous matrix surrounding the capsid of herpesviruses, 
which exists between the capsid and the envelope. There are over 15 tegument proteins 
identified in HSV-1[44] but only 4 tegument proteins have currently been identified  in 
BHV-1.  Known BHV-1 tegument proteins include VP8, VP16, VP22 and viral host cell 
shut off (Vhs) protein. VP8 is the most abundant tegument protein [40, 47] which was 
recently shown in vitro to prevent nuclear accumulation of the interferon-induced 
transcription factor, signal transducer and activator of transcription (STAT1) [48]. VP16 is 
a trans-inducing protein, which binds to host factors involved in protein synthesis to 
initiate transcription of immediate early viral proteins such as bICP0 [42]. BHV-1 VP22 
binds to the transporter associated with antigen presenting (TAP*) heterodimer and causes 
a conformational arrest that results in inhibition of peptide transport and degradation of 
TAP* [49]. Through inhibition of TAP*, VP22 down-regulates expression of MHC class 1 
which interferes with the detection of BHV-1 infected cells by cytotoxic T-lymphocytes. 
Vhs is encoded by UL41 gene and degrades pre-existing host mRNA and viral mRNA. 
Degradation of mRNA inhibits cellular protein synthesis and cellular defenses [50]. The 
tegument is a typical viral matrix in that it interacts with the capsid on one side and the 
cytoplasmic tails of the envelope-imbedded viral glycoproteins on the other side [44]. 
 
1.2.1.4.4 Envelope 
Similar to other alphaherpesviruses, the BHV-1 envelope is derived from the host cell 
membrane and is composed of a lipid bilayer with viral proteins inserted within it [51]. 
BHV-1 has twelve glycosylated envelope proteins including gB, gC, gD, gE, gG, gH, gI, 
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gK, gL, gM, gN and US9 [52]. BHV-1 requires gB, gD and gH/gL for viral attachment, 
entry and viral-host envelope fusion during infection [53, 54].   
 
1.2.1.5 Primary, Latent and Recrudescent BHV-1 infections Primary!BHV81!respiratory!infections!are!characterized!by!a!mucopurulent!nasal!discharge,!lacrimal!discharge,!high!fever,!loss!of!appetite,!weight!loss,!a!severe!cough,!excessive!salivation,!inflamed!nose!(hence!named!“red!nose”),!and!reduced!milk!yield!in!lactating!cows![55].!!Additionally,!the!mucosal!surfaces!lining!the!nasal!cavity!are!inflamed!and!develop!a!yellow!diphtheritic!membrane.!!!BHV81!is!the!causal!agent!of!Infectious!Bovine!Rhinotracheitis!(IBR)!in!the!respiratory!tract!and!Infectious!Pustular!Vulvovaginitis!(IPV!in!cows)!and!Infectious!Pustular!Balanoposthitis!(IPB!in!bulls)!in!the!genital!tract.!It!is!also!one!of!the!major!pathogens!associated!with!the!respiratory!disease!syndrome,!shipping'fever.!Systemic!BHV81!infection!can!cause!abortion!in!pregnant!cows,!infertility!in!females,!and!conjunctivitis!in!cattle![52,!55].!Furthermore,!BHV81!infection!can!cause!a!fatal!systemic!infection!and!encephalitis!in!newborn!calves![56].!!Although!most!of!the!BHV81!isolates!from!the!respiratory!tract!belong!to!the!BHV81.1!type,!subtypes!1.2a!and!1.2b!have!also!been!associated!with!clinical!respiratory!disease.!However,!the!initial!classification!of!these!subtypes!was!based!on!differences!in!restriction fragment 
length polymorphism (RFLP) in the viral DNA [37] and clinical syndromes caused by 
these isolates and may not reflect functional differences in viral gene expression or viral 
proteins.!
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A!respiratory!BHV81!infection!is!acquired!through!direct!nose8to!nose!contact!between!animals,!viral!transmission!on!fomites,!and!short!distance!aerosol!transmission!among!animals![57].!!Mucosal!epithelium!is!the!point!of!entry!for!BHV81!in!the!upper!respiratory!tract,!genital!tract!or!conjunctiva![58].!!Within!10!hours!of!infection,!BHV81!replicates!and!spreads!cell!to!cell!directly!to!adjacent,!uninfected!epithelial!cells!within!the!nasal!mucosa.!Subsequent!spread!of!the!virus!to!other!cells!can!occur!through!an!extracellular,!paracrine!manner,!approximately!three!hours!later![59].!!The!viral!infection!may!be!contained!locally!or!develop!into!a!systemic!infection,!which!may!lead!to!viremic!disease!and!abortion!in!pregnant!cows![60].!!The!primary!sites!of!respiratory!BHV81!infection!are!nasal!turbinates,!pharyngeal!tonsils!and!trachea![61].!!Primary!BHV81!infection!lasts!9810!days!and!then!spreads!to!the!nervous!system!via!cell8to8cell!spread!into!sensory!neurons!that!innervate!the!URT,!and!becomes!latent!in!the!trigeminal!ganglia![55].!!!During!viral!latency,!gene!expression!of!immediate!early!genes,!such!as!bICP0,!are!reduced![62]!and!viral!gene!expression!is!limited!to!latency!related!(LR)!gene!and!open!reading!frame8E!(ORF8E).!!Infectious!virus!particles!are!no!longer!detected![63].!Herpesviruses!establish!lifelong!latency!with!no!clinical!symptoms!until!reactivated!by!external!factors!such!as!stress!or!the!use!of!a!synthetic!corticosteroid,!such!as!dexamethasone,!in!experimental!situations![64]!.!!!Upon!reactivation,!BHV81!spreads!cell8to8cell!from!neuronal!cells!to!the!mucosal!epithelium!of!the!URT!and!in!this!way!is!shielded!from!extracellular!BHV81!
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neutralizing!antibodies.!Recrudescent!infections!are!characterized!by!the!sudden!appearance!of!detectable!infectious!BHV81!particles!in!nasal!or!ocular!secretions![65].!During!recrudescence,!there!is!increased!expression!of!IE!viral!genes!and!reduced!expression!of!LR!genes!within!neurons![65].!!
 
1.2.1.6 BHV-1 and the Bovine Respiratory Disease (BRD) Complex Bovine!respiratory!disease!complex!(BRDC),!also!known!as!shipping'fever!and!bovine'
pneumonia!occurs!worldwide!and!has!a!significant!economic!impact!in!Canadian!feedlots!with!an!estimated!cost!of!almost!$12/animal![66].!BRDC!is!a!multifactorial!disease!resulting!from!co8infection!by!multiple!pathogens!and!infection!is!exacerbated!by!stressors!like!transportation!and!malnutrition![67,!68].!BRDC!has!been!associated!with!multiple!viruses,!including!BHV81,!bovine!viral!diarrhea!virus!(BVDV)!type!1!and!2,!parainfluenza83!(PI83)!virus!and!bovine!respiratory!syncytia!virus!(BRSV)![69].!!Numerous!bacteria!that!are!members!of!the!commensal!microbiome!in!the!upper!respiratory!tract!are!also!associated!with!BRDC.!These!bacteria!include!Mannheimia'haemolytica,!Pasteurella'multocida,'Histophilus somni, 
and Mycoplasma bovis'[68,'70]'.! !BRD!is!usually!initiated!by!a!primary!viral!infection!followed!by!a!secondary!bacterial!infection.!Yates!and!colleagues!described!a!BRDC!viral8!bacterial!synergy!following!an!initial!BHV81!infection.!!BHV81!infection!suppressed!host!immune!responses,!and!increased!the!host’s!susceptibility!to!a!fatal!secondary!bacterial!infection![70].!!Possible!mechanisms!mediating!immunosuppression!include:!
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• Lytic!BHV81!infection!of!ciliated!epithelium!and!goblet!cells!lining!the!mucosal!surfaces!of!the!URT!impairs!mucin!production!and!the!mucosal!clearance!function!of!the!epithelium.!This!increases!the!opportunity!for!bacterial!colonization!of!the!lung!through!a!decreased!capacity!to!remove!bacteria![71].!
• BHV81!infection!of!activated!T8helper!cells!(CD4+)!leads!to!programmed!death!of!CD4+!cells.!This!impairs!cell8mediated!immune!response!and!host!defense!response!against!potential!secondary!bacterial!infections![72].!
• BHV81!infection!decreases!neutrophil!infiltration!of!the!lungs!in!cattle!by!modifying!pulmonary!endothelial!cells’!response!to!pro8inflammatory!cytokines!like!TNF8α!and!decreasing!binding!of!neutrophils!to!endothelial!cells.!Impaired!neutrophil!recruitment!may!result!in!increased!bacterial!growth!and!colonization![73].!!
1.2.2 IMMUNE RESPONSE TO A PRIMARY BHV-1 INFECTION 
1.2.2.1 INNATE IMMUNE RESPONSES  
1.2.2.1.1 Non-immune barriers 
Non-immune barriers refer to physical and biochemical host defense mechanisms 
orchestrated locally in tissues without the recruitment of immune cells. These mechanisms 
include mucus secretion by goblet cells, mucociliary clearance by ciliated epithelial cells, 
antimicrobial peptides produced by epithelial cells, coughing and physical barriers such as 
hairs in the external nares, and the tight junctions of epithelial cells.  
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1.2.2.1.2 Antimicrobial peptides 
Antimicrobial peptides are short peptides or polypeptides less than 200 amino acids long 
and produced by cells within the epithelium. Bovine β-defensin DEF103, which is 
produced by basal epithelial cells in bovine buccal epithelium, is transcriptionally 
upregulated following a BHV-1 infection and may be an important host defense against 
BHV-1 infection [8]. Although other β-defensins such as tracheal antimicrobial peptide 
(TAP) and lingual antimicrobial peptide (LAP) have been shown in cattle to have 
microbial activity against gram positive and negative bacteria causing BRD [7, 74], their 
role in a BHV-1 infection remains unknown. 
 
1.2.2.1.3 Mucopolysaccharides 
There is limited information on the role of mucopolysaccarides during a BHV-1 infection. 
However, BHV-1 infection can increase glycoconjugate expression in the nasal mucosa 
which enhances adhesion and colonization by commensal bacteria involved in BRD [75]. 
Analysis of glycoconjugate composition in the bovine nasal mucosa revealed that three N-
acetylgalactosamine specific lectins: Dolichos biflorus, Glycine max, and Vicia villosa 
were more reactive in bacterial adhesion following BHV-1 infection [75].  
 
1.2.2.1.4 Interferons  
Interferons (IFN) are an important component of innate immune defenses against 
viral infections and IFNs activate a variety of anti-viral defense mechanisms.  There are 
three known types of IFNs: Type I, II, and III. Type I bovine IFNs include IFN-α, with at 
least 9 known subtypes, and IFN-β with 3 known subtypes [76]. IFN-γ is the sole member 
of type II interferons, while IFN-λ is the only member of type III bovine IFN.  Type I 
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interferons are produced by all nucleated cells while type II interferons are produced 
primarily by Natural Killer (NK) cells, Natural Killer T (NKT) cells, and T-lymphocytes. It 
is currently not known which cells types produce type III IFNs. IFNs act in a two-step 
mechanism. IFN secretion is followed by IFN-activated receptor signaling that induces 
transcription of antiviral effector genes and translation of proteins, which interfere with 
viral replication. This interference with viral replication is the defining characteristic of 
interferon proteins which originally gave rise to the name, Interferon [77]. 
 
1.2.2.1.4.1 Interferon production 
IFN production is induced following recognition of viral components by pattern 
recognition receptors (PRR) such as Toll-like receptors (TLRs) and retinoic acid inducible 
gene -1 (RIG -1)-like receptors (RLRs). PRRs recognize virus components at the host cell 
surface and viral nucleic acids in endosomal compartment membranes. During a primary 
BHV-1 infection, bovine TLR 7 and 8 are transcriptionally up-regulated in nasal mucosa 
and lung epithelium but downregulated in tracheal epithelium [78]. In contrast, TLR 3 and 
9 gene expression are not changed in the infected nasal mucosa and lung epithelium but 
downregulated in tracheal epithelium during a primary infection [78]. In contrast, during 
BHV-1 reactivation from latency, TLR 3 gene expression was up-regulated in nasal 
mucosa but no other tissues [78]. During reactivation, an upregulation of TLR7 and 8 gene 
expression was observed in tracheal and lung epithelium while expression of these genes 
did not change in the nasal mucosa [78]. These analyses indicate that TLR transcript levels 
during a BHV-1 infection vary based on tissue type and phase of BHV-1 infection. After 
engagement of TLRs, a signaling cascade is initiated with multiple transcriptional factors, 
such as interferon regulatory factors (IRFs) and NF-κB, leading to transcription of 
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interferons and other pro-inflammatory cytokines. Further, interferon transcripts are 
translated and ultimately secreted by infected cells and then act in either an autocrine or 
paracrine manner. BHV-1 is a potent inducer of IFN-α and -γ during acute respiratory 
infections [67]. Secreted Type I and II IFNs bind to the interferon receptors IFNAR and 
IFNGR, respectively, on the cell surface and initiate signalling pathways such as the 
JAK/STAT (as reviewed in [79]) which  establishes an antiviral state through the induction 
of IFN-induced antiviral effector genes. 
 
1.2.2.1.4.2 Interferon-induced antiviral immune responses 
 
The antiviral state is established following activation of interferon-stimulated genes (ISG) 
and subsequent production of antiviral effector proteins such as double-stranded RNA-
dependent protein kinase R (PKR), Myxovirus resistance (Mx) proteins, oligoadenylate 
synthetase-RNAase L (OAS-RNAse L) and BST-2 or Tetherin [80]. These antiviral 
proteins interact with different steps in the viral life cycle to inhibit replication, assembly, 
and release of infectious virions.  PKR degrades dsRNA and RNase L degrades ssRNA, 
which inhibits viral protein synthesis. Mx1 binds to viral components in the cytosol and 
has the capacity to inhibit replication by binding to viral proteins during the uncoating 
process of the virus replication cycle [80]. Similarly, Mx1 also inhibits assembly of nascent 
virions by binding newly formed virus proteins and making them unavailable for assembly. 
It is not known however, if type I and II IFNs activate similar ISGs and antiviral effector 
proteins in bovine cells. 
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1.2.2.1.4.3 Interferon evasion mechanisms by Alphaherpesvirinae 
 Multiple!alphaherpesviruses!have!been!shown!to!replicate!in!the!presence!of!interferons!and!it!has!been!demonstrated!in'vitro!that!they!can!evade!the!activity!of!interferon8induced!antiviral!effector!proteins.!!Treatment!of!calves!with!recombinant!bovine!IFN8αI!did!not!reduce!virus!shedding!following!experimental!BHV81!challenge![81].!Similarly,!infection!of!calves!with!a!recombinant!BHV81!virus!expressing!IFN8γ!did!not!reduce!viral!shedding!compared!to!a!wild8type!strain![82].!Although!BHV81!is!a!potent!inducer!of!type!I!and!II!interferon!secretion!during!primary!respiratory!infections![67],!BHV81!ICP0!(bICP0)!and!bICP27!have!been!reported!to!induce!degradation!of!IRF83!and!inhibit!the!activity!of!IFN8β!promoters,!respectively.!Thus,!both!of!these!viral!proteins!can!inhibit!IFN8β!transcription![83,!84].!BHV81!bICP0!has!also!been!reported!to!inhibit!the!intermediate!kinases!involved!in!the!interferon8signalling!pathway,!including!TANK8!binding!kinase!1!(TBK1)!and!IκB!kinase!epsilon!(IKKε),!which!can!also!result!in!inhibition!of!IFN8β!promoter!activity[85].!These!studies!were!performed!in'vitro!using!a!variety!of!cell!types!that!may!or!may!not!reflect!the!biological!responses!of!bovine!mucosal!epithelial!cells.!BHV-1 infection in vivo results in the production of both IFN-α 
and IFN-γ [67] even though BHV-1 encodes bICP0, which induces proteosome-dependent 
degradation of IRF-3 [84]. Therefore, one mechanism by which BHV-1 may evade IFN-
induced antiviral effector proteins may be through inhibition of ISG transcription. 
However, it is not known whether BHV-1 evades IFN8α and 8γ-induced antiviral effector 
proteins at the level of ISG transcription, translation, or post-translational modification.  
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Several other!IFN!evasion!mechanisms!have!been!identified!for!other!members!of!the!Alphaherpesvirinae!subfamily.!For!example,!HSV81!encodes!gene!products!that!block!IFN8α!production!and!inhibits!the!antiviral!activity!of!PKR!through!dephosphorylation!of!eIF82![86].!Varicella!Zoster!Virus!(VZV)!also!inhibits!PKR!through!phosphorylation!of!eIF82α![87].!!Therefore,!BHV81!may!employ!a!variety!of!mechanisms!to!evade!the!antiviral!activity!of!Type!I!and!II!IFNs!and!further!investigations!are!required!to!fully!understand!the!role!of!IFNs!in!the!host!innate!immune!response!during!an!acute!BHV81!infection.! 
 
1.2.2.1.5 Natural Killer (NK) and NK-like cell responses 
 
NK cells and NK-like cells are non-MHC- restricted lymphocytes, which kill infected cells 
by releasing cytotoxic granules containing perforin and granzyme B. Although similar to 
cytotoxic T-lymphocytes in their mechanism of action, NK cells are innate immune cells 
and not antigen-specific. NK cells isolated from the blood of calves following BHV-1 
infection were first reported as non-adherent, non-B, non-T-cells which mediated the lysis 
of non-syngeneic BHV-1 infected cells [88]. The first analysis of cytotoxic activity during 
a primary BHV-1 respiratory infection reported an increase in non-MHC restricted killing 
of BHV-1 infected cells following viral infection. These non-MHC restricted leukocytes 
were isolated from the lung parenchyma but the phenotype of these cells was not further 
analyzed. 
NK cells bear activation and inhibitory receptors and recognize target cells with reduced or 
no MHC expression [89]. NK cells also recognize and kill BHV-1 virions with antibody 
bound to their surface. CD2+CD4+ and CD8+ NK-like cells are another subset of innate 
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lymphoid cells shown to be non-MHC restricted and stimulated by cytokines to kill BHV-1 
infected cells [90]. Although identified in humans and mice, it remains to be confirmed 
that cattle have functional natural killer T (NKT) cells,  which in other species recognize 
lipid antigens in the context of a cell surface molecule, CD1d  [91]. The CD1d gene is 
absent in cattle [91] but bovine NKT cells may be activated in a CD1d-independent 
manner [92]. It remains to be determined whether conventional NK cells or NKT cells play 
a role in the control of BHV-1 infections.  
 
1.2.2.1.6 Macrophage responses  Macrophages!are!innate!immune!cells!that!phagocytose!extracellular!pathogens.!During!a!primary!BHV81!infection,!macrophages!are!stimulated!by!IFN8γ!and!can!kill!BHV818infected!cells!through!a!non8MHC!restricted!mechanism!within!2!days!after!pulmonary!infection![71,!90,!93].!!Following!BHV81!infection,!alveolar!macrophages!increase!in!number!in!the!lungs!with!increased!expression!of!MHC!class!II!and!display!increased!Fc8mediated!phagocytosis![94].!It!has!also!been!shown!that!macrophages!kill!BHV81!infected!cells!through!antibody8dependent!cellular!cytotoxicity!(ADCC)!later!during!a!primary!infection![95].!BHV81!also!infects!macrophages!and!can!inhibit!these!antiviral!functions![71,!96].!!
1.2.2.1.7 Polymorphonuclear (PMN) cell response PMNs,!including!neutrophils!and!eosinophils,!are!phagocytes!with!PRRs!and!receptors!for!complement!proteins.!Neutrophils!have!been!shown!to!mediate!ADCC!against!BHV81!infected!cells!in!the!presence!of!complement!and!low!concentrations!of!
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BHV81!specific!antibody![97].!!Activated!neutrophils!can!kill!BHV81!infected!cells!through!the!release!of!cytotoxic!granules!after!binding!to!either!activated!complement!proteins!or!antibody!bound!to!infected!cells![98].!BHV81!infected!cells!and!macrophages!produce!IL88!which!is!a!chemokine!involved!in!recruitment!of!neutrophils.!BHV81!also!expresses!a!glycoprotein!(gC)!that!mimics!the!chemokine!receptors!on!PMNs!and!reduces!recruitment!of!these!cells!to!the!site!of!infection![99].!Neutrophils!can!also!produce!defensins!in!response!to!BHV81!infection![2]!but!it!is!not!known!if!these!defensins!have!direct!antiviral!activity.!Thus,!neutrophils!may!be!important!innate!immune!effector!cells!following!a!primary!BHV81!infection. 
 
1.2.2.2 ADAPTIVE IMMUNE RESPONSE 
BHV-1 infections are thought to be controlled and cleared through the combined activity of 
both innate and adaptive immune responses. Adaptive immune responses are characterized 
by antigen specificity and immunological memory but this response takes days to weeks to 
develop. The adaptive immune response to BHV-1 infection includes both a humoral 
response, which involves virus neutralizing (VN) antibodies, and a cell-mediated immune 
response. VN antibodies are secreted by plasma cells, which differentiate from virus-
specific B-cells, and cell-mediated immune responses are mediated by T-cells.   
 
1.2.2.2.1 Humoral immune response 
Three major BHV-1 glycoproteins, gB, gC and gD, have been identified as immunogenic 
and induce antibody responses during a primary BHV-1 infection [100].  Antibodies (Abs) 
specific to these viral glycoproteins are able to prevent viral infection of cells. IgA 
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antibodies against BHV-1 glycoproteins are induced in the URT [23] and secreted at 
mucosal surfaces while BHV-1 specific IgG antibodies can be detected in serum [23, 101]. 
Antibodies also bind and kill BHV-1 infected cells through ADCC mediated by PMNs, 
macrophages and NK cells in a non-MHC restricted manner [95]. BHV-1 has, however, 
developed mechanisms to evade the host humoral response by using intercellular egress 
across the tight junctions between epithelial cells to facilitate direct cell-to-cell spread. This 
mechanism of spreading viral infection avoids viral neutralization and opsonisation by 
extracellular antibodies [102]. This evasion mechanism highlights that the humoral 
response fails to restrict all modes of viral infection to adjacent cells and cell-mediated 
responses are thus essential in mediating clearance of BHV-1 infection.  
 
1.2.2.2.2 Cell-mediated Immune Responses 
Adaptive cell-mediated immune responses are MHC-restricted and mediated by T-cells.  
MHC-restriction refers to the immunological requirement of antigenic peptides to be 
presented complexed with “self” MHC molecules on the surface of antigen presenting cells 
(APCs) for recognition by T-cells through a T-cell receptor. 
 
1.2.2.2.2.1 Antigen Presenting cells (APCs) 
Dendritic cells and macrophages are immune cells that bridge the innate and adaptive arms 
of the host immune system through antigen presentation. Macrophages phagocytose 
pathogens and present antigens on MHC Class II but also present antigens through MHC 
Class I when infected. DCs are known as “professional APCs” which present antigens and 
have the capacity to activate naive T-cells [103]. DCs present peptides from BHV-1 
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proteins within the context of both MHC class I and II molecules and also co-express the 
co-stimulatory molecules required to activate naïve T-cells [103].  
 
1.2.2.2.2.2 T-cell response 
T-cells are characterized by the co-expression of variant T-cell receptors (TcR) with the 
invariant proteins that form the CD3 complex. Variant T-cell receptors (TcR) may be 
composed of heterodimer αβ or γδ chains. Each variant TcR protein is encoded by 
recombination of gene segments consisting of variable (V), junction (J), diversity (D), and 
constant (C) sequences.  Most of the diversity exists in the complementarity-determining 
region 3 (CDR3), located at the centre of the TCR antigen binding site, which effectively 
increases the range of antigen recognition [104].  αβT-cells can be further divided into 
subsets based on the co-expression of other accessory proteins, such as CD4 and CD8.  !!
1.2.2.2.2.2.1 T-helper (CD4+) T cells 
 
CD4 T-cells recognize antigenic peptides bound to MHC class II complexes on APCs and 
secrete cytokines that can activate or regulate downstream cell-mediated immune 
responses [105]. CD4 T cells can be further subdivided into functional subsets on the basis 
of the cytokines that they secrete. Th1 cells secrete IL-2, IL-3 TNF-α, TNF-β and IFNγ 
and Th2 cells secrete IL-3, IL-4, IL-5, IL-6 and IL-10 [106]. Further, TH17 cells secrete 
IL-17, IL-17F, IL-21 and IL22 [107]. Th3 cells and regulatory!T8cells!produce TGF-β 
and IL810![107,!108].!CD4+ T-cells have been shown to recognize a variety of BHV-1 
proteins, including gB, gC, gD and VP8 [109, 110]. BHV-1 may evade CD4+ T cell 
responses by infecting these cells when activated and inducing programmed death [72, 
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111]. BHV-1 may also prevent CD4 T cell activation by down-regulating MHC II 
expression on APCs which then disrupts antigen presentation [50]. 
 
1.2.2.2.2.2.2 Cytotoxic (CD8+) T-cells 
 
CD8+ T- cells, also known as cytotoxic T-lymphocytes (CTLs), recognize antigenic 
peptides complexed with MHC Class I expressed on infected cells. Activated CD8+T-cells 
can then produce IFN-γ and release cytotoxic granules. These cytotoxic granules contain 
perforin and granzyme B; proteins involved in forming membrane attack complexes and 
inducing programmed cell death in infected cells. Cytolytic CD8+ T-cells can induce 
apoptotic death of BHV-1 infected macrophages through a perforin-independent 
mechanism [112].  BHV-1 gB protein induces a strong CTL response and elicits memory 
CD8+cells [113].  CD8+ T-cells have been shown to also target the BHV-1 tegument 
protein, UL49, and the immediate early proteins ICP4, ICP22, and the circ [114], an IE 
protein encoded by a circ gene located at the terminal repeats (TR) – UL junction of the 
circular BHV-1 genome [115]. BHV-1, in turn, evades CD8+T-cell responses by down- 
regulating cell surface MHC Class I expression through inhibition of transporter associated 
antigen presentation (TAP) by the BHV-1 protein encoded by UL49.5. 
 
1.2.2.2.2.2.3 γδT-cells 
 
 γδT-cells are the most abundant bovine T-cells in the blood of young animals, comprising 
up to 60% of bovine peripheral blood mononuclear cells (PBMCs) [116]. The majority of 
γδT-cells express the WC1 protein and co-express CD8 [117, 118]. CD8+γδT-cells are 
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recruited to mucosal surfaces by the CCL19/CCL21 chemokines and bind to mucosal 
addressin cell adhesion molecule 1 (MAdCAM-1) [119]. These CD8+ γδT-cells may be 
important in host defenses against infections at mucosal surfaces. Bovine  γδT-cell 
frequency has been shown to increase significantly in blood as early as 1 day after BHV-1 
infection [120]. Previous studies have also shown that  γδT-cells are activated following 
immunization with a modified-live BHV-1 vaccine and are re-activated in vitro by 
exposure to live BHV-1 [121]. Activated bovine!γδT-cells spontaneously produce IL-10 
and supress antigen-specific CD4 and CD8 T-cell proliferation. γδT-cells proliferate in 
response to IL-10 and TGF-β production by APCs which present peptides from Foot and 
Mouth disease Virus [116]. However, the role of γδT-cells during a primary BHV-1 
infection remains uncertain. 
 
1.2.3 LYMPHOCYTE MARKERS AND TRAFFICKING 
 
1.2.3.1 LYMPHOCYTE MARKERS 
This review highlights that immune responses to a primary BHV-1 infection are diverse 
and involve multiple immune cell populations. Monoclonal antibodies (mAbs) have been 
instrumental in the identification and characterization of these cells. Lymphocyte surface 
proteins have been used to identify both cell lineage and the state of cell activation or 
differentiation [122, 123]. Lymphocyte surface proteins may be receptors involved in 
antigen recognition or interactions with cytokines, cell adhesion molecules, and a variety 
of signal transduction functions [124]. 
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1.2.3.1.1 History  
Numerous immunological studies have been made possible through the collaborative work 
of a consortium of veterinary immunologists. Four international workshops have been 
organized to establish consistent nomenclature for ruminant leukocyte differentiation 
antigens [125-128]. The nomenclature used for these leukocyte antigens is based on  
comparison with human leukocyte antigens and individual molecules are designated as a 
cluster of differentiation (CD) [124]. CD refers to cell surface polypeptides expressed on 
immune cells that are recognized by monoclonal antibodies. Further, multiple mAbs 
recognizing the same cell surface protein were grouped to the same CD utilizing flow 
cytometry and statistical techniques [123]. Although much progress has been made in the 
past 30 years [123, 125], the limited availability of commercial mAbs against numerous 
bovine proteins continues to impede progress in bovine immunology. However, existing 
mAbs have allowed identification and quantification of multiple lymphocyte 
subpopulations, facilitated studies of lymphocyte distribution within tissues, and supported 
the analysis of lymphocyte trafficking. 
 
1.2.3.1.2 Identification of cell subpopulations 
Identification of lymphocyte surface proteins by mAbs makes possible the phenotypic 
analysis of multiple lymphocyte subpopulations. Common lymphocyte activation markers 
such as CD26 and CD50 have been reported to be expressed on activated bovine CD4, 
CD8, γδT-cells and NK cells [129]. Multiple lymphocyte proteins have been identified for 
each one of the major lymphocyte populations, including B-cells, T-cells and NK cells. 
 
 
! 35!
1.2.3.1.2.1 Identification of B-cell subpopulations 
B-lymphocytes are located primarily in the follicular region and marginal areas of 
lymphoid tissues and organs [130]. Surface immunoglobulins (sIg) located on the 
membrane of B-cells were first demonstrated and quantified in the early 1970s by 
Rabellino and colleagues [131] using fluorescein-conjugated antisera. These analyses 
revealed that 45% of spleen and bone marrow lymphocytes and 7-14% of peripheral blood 
and lymph node cells expressed sIg. It was later shown that sIg could also be used to 
identify bovine B-cells and that sIg+ B-cells constituted about 40% of bovine peripheral 
blood leukocytes [132, 133]. B cells expressing different antibody isotypes were also 
investigated and the majority of B-cells isolated from the blood of cattle were shown to 
express IgM [125, 134] while a small fraction expressed IgG and IgA[134]. A non-sIg 
protein, CD21, was also reported to be expressed by IgM and IgG-expressing mature B-
cells in bovine peripheral blood [135]. Another bovine B-cell surface protein is BoWC4, 
which is a possible homolog of human CD19 and this protein has been shown to be 
expressed on B cells at mucosal surfaces [124, 136]. Other B-cell subsets have been 
defined by the co-expression of other surface proteins such as:  BoWC5 [136] BoWC6 
[137], WC10 [138], CD5 [139], and CD11b [139]. 
 
1.2.3.1.2.2 Identification of T-cell subpopulations 
The original method for identifying bovine T-cells was through the binding of sheep 
erythrocytes to form rosettes, a phenomenon known as erythrocyte rosetting (E-rosetting) 
[140]. Selective binding of lectins was also used to identify most bovine T-lymphocytes 
but about 2% of B-cells also bind lectin [141, 142]. Due to the inconsistency in 
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reproducing results with these methods, significant effort was made to develop mAbs to 
detect T-cell lineage specific molecules [126, 128, 134]. A mAb detecting a common T-
cell antigen expressed on all bovine T-cells was introduced by Rabinovsky and Yang as a 
T-cell surface molecule analogous to the human CD3 molecular complex [143]. CD3 is a 
multi-polypeptide complex associated with the T-cell receptor proteins and is involved in 
signal transduction during T-cell activation [144]. Bovine CD2, an orthologue of the 
human CD2, was also expressed on the surface of 60% of PBMCs and the majority of 
these cells were found to co-express either CD4 or CD8 [145]. The absence of CD2 
expression on conventional NK cells has been used to differentiate between CTLs and 
cytotoxic NK cell populations [146]. Bovine T-helper (Th) cells were first identified as 
MHC Class II restricted CD4+ cells, which modulate adaptive immune responses such as 
antibody production. These Th cells could comprise as much as 25 to 30% of the 
mononuclear cells isolated from bovine blood [147, 148]. Bovine CD8+ T-cells were also 
shown to be cytotoxic T-cells that were MHC Class I restricted and represented 
approximately 20% of mononuclear cells present in bovine blood [149].  Another T-cell 
subpopulation identified in cattle was CD2-/CD4-/CD8-/WC1+ γδTcR-cells, which are 
abundant in young calves and constitute approximately 25% of blood mononuclear cells 
and under 5% of T-cells in lymphoid tissues [150]. A recent study demonstrated that 
activated bovine T-cell populations could be distinguished from resting T-cells [129].  
CD25, CD45R0 and signaling lymphocytic activation molecule family member 9 
(SLAMF9) expression is up-regulated on activated γδT-cells and CD25, CD44 and 
CD45R0 expression is up-regulated on activated CD4+ and CD8+ T-cells[129, 151]. Even 
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with the number of available mAbs for markers on T-cell subpopulations, CD3 and the T-
cell receptor (TCR) remain the only lineage specific markers used to identify all T-cells.  
 
1.2.3.1.2.3 Identification of NK cell populations 
NK-cells were initially defined in mice and humans as large granular lymphocytes (LGL) 
with non-MHC restricted cytotoxicity [152]. Cells with similar morphological and 
functional characteristics were subsequently identified in cattle [153] but no lineage-
specific cell surface proteins have been identified. Human NK-cells, were initially 
identified by their expression of CD56 and CD16 which divided NK-cells into 
CD56high/CD16+ and CD56low/CD16+/- subpopulations. Murine NK-cell subpopulations 
were identified through their expression of CD27 and CD11b [154].  MAbs were not 
available for orthologous molecules on bovine NK-cells but recently a mAb was generated 
that specifically reacted with the natural cytotoxicity receptor (NCR), NKp46 [155]. 
Bovine NK cells are now identified as a separate lymphocyte lineage through the absence 
of T-cell lineage markers [153] such as CD2 [156] and CD3. Thus, bovine NK-cells have 
been identified as both NKp46+CD3- [157] and NKp46+CD2- [146]. A recent study also 
reported that expression of gp96, a peptide binding chaperone protein in the endoplasmic 
reticulum [158] and the absence of SLAMF9 can be used to identify activated bovine NK 
cells and distinguish them from T-cells [129].   
Non-conventional T-lymphocyte populations which co-express the T-cell marker, CD3 and 
NKp46 have recently been identified in multiple species including bovine [157], porcine 
[159] and sheep [160] . The first non-conventional T-cells were discovered in 
reprogrammed human cytotoxic T-lymphocytes which co-express CD3 and NKp46 in 
! 38!
celiac disease [161]. Since then, other non-conventional T-cells including Natural killer T-
cells (NKT) and mucosal associated invariant T-cells (MAIT) have been shown to co-
express CD3 and NCR [162, 163]. Bovine non-conventional T-cells isolated from blood 
have also been shown to have non-MHC restricted cytotoxicity during a parasitic infection. 
 
1.2.3.1.3 Cytoplasmic Proteins Present in Cytotoxic Lymphocytes 
Cytotoxic lymphocytes are characterized by production and secretion of cytotoxic 
granules, which contain proteins such as perforin and granzyme B. Once perforin and  
cytotoxic lymphocyte lineages that can kill tumour cells and infected host cells. These 
cytotoxic granules are highly conserved and have been used to identify activated cytotoxic 
lymphocytes in multiple species, including humans [165, 166], pigs[167] and cattle[168]. 
 
1.2.3.2 LYMPHOCYTE RECRUITMENT 
Naïve lymphocytes originate from primary lymphoid organs such as thymus and bone 
marrow and migrate to secondary lymphoid tissues, including lymph nodes, spleen and 
other organized lymphoid tissues. Naive lymphocytes can then recirculate between blood 
and secondary lymphoid tissues until they encounter foreign antigen or die [169]. 
Following an interaction with antigen, naïve lymphocytes are activated, and with 
appropriate co-signals proceed through clonal expansion before homing to the infected 
tissue as effector lymphocytes. Lymphocyte extravasation from blood vessels and into 
lymphoid or peripheral tissues involves specific and tightly regulated interactions between 
lymphocytes and adhesion molecules expressed on high endothelial venules (HEVs) [170]. 
Lymphocyte recruitment from immune inductive to effector sites during infection involves 
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chemokines produced within infected tissues and an interaction between adhesion 
molecules expressed on both leukocytes and high endothelial venules (HEVs).  The 
interactions among these three components determine tissue specificity and the timing of 
recruitment. Thus, the stage of an inflammatory response which elicits specific lymphocyte 
recruitment is determined by the coordinated expression of chemokines and adhesion 
molecules [170]. 
 
Clearance of infections by cell-mediated immune responses requires recruitment of 
effector immune cells to the site of infection. The mechanism mediating leukocyte 
extravasation were first described over 25 years ago as a three-step process of 
leukocyte rolling, followed by leukocyte adhesion to endothelium, and subsequent 
migration of leukocytes through HEVs into lymphoid and peripheral tissues [170]. 
The definition of this mechanism has since been updated to include more steps in 
the leukocyte adhesion and transmigration cascade including leukocyte slow rolling, 
adhesion stabilization, intraluminal crawling, paracellular and transcellular 
migration and migration through the basal membrane of the endothelial cells into 
the inflamed tissue [171].    
 
1.2.3.2.1 Adhesion Molecules 
Adhesion molecules expressed on endothelial cells in mammalian tissues interact with their 
ligands on leukocytes and facilitate leukocyte rolling and attachment during leukocyte 
extravasation [170, 171]. Selectins and integrins are well-documented adhesion molecules 
expressed on endothelial cells and leukocytes in multiple species. [119, 151, 172, 173]. E-
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selectin and P-selectin are expressed on endothelial cells and L-selectin is expressed 
mostly on leukocytes including lymphocytes [171]. Naïve T-cells recruited to the lymph 
nodes (LN) express L-selectin, which interacts with its carbohydrate ligand expressed on 
HEVs in human LN and tonsils [172] The expression of bovine L-selectin on lymphocytes 
also determines their tissue tropism as demonstrated by high L-selectin expression on 
lymphocytes in peripheral lymph nodes and a contrasting low L-selectin expression on 
lymphocytes in mucosal sites [174] . In cattle, P-selectin on bovine endothelial cells binds 
to LPS-activated peripheral blood leukocytes [175] and E-selectin is expressed on bovine 
aortic endothelial cells [176]. The P-selectin ligand, P-selectin glycoprotein ligand -1 
(PSGL-1) was initially described as a ligand of P-selectin but has since been shown to bind 
to all three selectins [171, 177]. Increased expression of PSGL-1 on B, T and NK cells was 
observed in the presence of platelets indicating that platelets may promote lymphocyte 
adhesion to endothelial cells [178]. Furthermore, intercellular adhesion molecule-1 
(ICAM-1) and vascular cell adhesion molecules (VCAM-1), which are members of the 
immunoglobulin supergene family, are also expressed on bovine endothelial cells 
following experimental exposure of these cells to lipopolysaccharide (LPS) [179]. ICAM-1 
and VCAM-1 bind to the integrins lymphocyte function associated antigen -1 (LFA-1 ) and 
α4β1 (also known as Very Late Antigen: VLA-4 ) expressed on lymphocytes  [179]. This 
finding shows that ICAM-1 and VCAM-1 expression is induced during bacterial infection 
and may play an important role in lymphocyte recruitment during infection. Similarly, 
bovine mucosal vascular addressin cell adhesion molecule 1 (MadCAM-1) is expressed on 
HEVs in mucosal sites including in the mesenteric lymph nodes (MLN) and the ileal 
mucosa and lamina propria [119]. Bovine CD8+ γδT-cells have been shown to bind to 
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MadCAM-1 and accumulate in tissues with high MAdCAM-1 expression, while few 
bovine CD8+ γδT-cells were recruited to tissues with low or no MAdCAM-1 expression 
[119]. Bovine CD8+γδT-cells were also shown to express the MAdCAM-1 receptor, α4β7 
[119]. These findings are consistent with the current concept that expression of MAdCAM-
1 regulates lymphocyte recruitment to mucosal sites. 
 
Following leukocyte slow rolling and adhesion stabilization, leukocytes transmigrate 
through the HEVs or between the HEVs (paracellular migration) and basal membrane of 
the HEVs into the inflamed tissue and home to the site of infection. The interaction 
between adhesion molecules on HEVs and lymphocytes results in conformational change 
in the HEVs with increased expression of adhesion molecules in the tight junction between 
endothelial cells. This facilitates the migration of recruited cells from the lumen of the 
blood vessel, through the endothelial cells and into the inflamed tissue [171].  Junctional 
adhesion molecules (JAMs) are molecules expressed on the lateral membrane of 
endothelial cells, which regulate leukocyte transendothelial migration [180]. There are 
three known types of JAMs including JAM-A, JAM-B and JAM-C in human and mice 
[180-182] which bind to LFA-1[183] VLA-4 (α4β1) [182] and macrophage antigen -1 
(Mac-1) [184] respectively. These JAM ligands are expressed on lymphocytes and are 
important for lymphocyte recruitment into tissues. The functional JAM orthologues in 
cattle are however still unknown. It is predicted, however, that bovine JAMs – A, B and C 
exist based on genetic similarity, computerized annotations and pathway reconstruction 
analysis in the database, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway 
[185, 186]. 
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1.2.3.2.2 The role of Chemokines 
Chemokines are low molecular weight chemoattractant cytokines produced by multiple 
cell populations during inflammation. Chemokines increase adhesion molecule expression 
and direct circulating leukocytes to migrate up a chemokine gradient toward sites of 
inflammation. This chemotaxis is directed by chemokine binding to specific chemokine 
receptors differentially expressed on circulating leukocyte subpopulations [187].  
 
Studies in chemokine-deficient animal models have been used to identify chemokines 
involved in lymphocyte recruitment in humans and mice [188]. CCL21 is a 
chemoattractant shown to recruit B and T-lymphocytes to lymphoid and non-lymphoid 
tissues including mesenteric lymph nodes, small and large intestine and lungs in mice 
[189].  CCR6-deficient mice experimentally treated with cockroach allergen (CA), were 
shown to produce CCL20 in murine lungs in an allergic asthmatic response and had over a 
10-fold reduction in IgE production compared to wild–type mice. These observations 
support the conclusion that CCL20 and CCR6 are critical for recruitment of B-
lymphocytes [190]. Similarly, CXCL13- expressing transgenic mice demonstrated that 
overexpression of CXCL13 in intestinal epithelial cells resulted in the recruitment of B-
lymphocytes, NK- cells and lymphoid tissue-inducer cells (LTi) [191]. 
 
Non-MHC restricted lymphocytes were recruited to the lungs of calves following BHV-1 
infection [192], but the identity of these cells has not been confirmed. In humans, Lande et 
al have shown that CD4+ and CD8+ T cells and conventional NK cells are recruited to 
CCL3, CCL4, CXCL9 and CXCL10-producing dendritic cells following a Mycobacterium 
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tuberculosis infection [193]. Furthermore, Type 1 interferons were shown to induce the 
expression of CXCL10 in Mycobacterium tuberculosis-infected dendritic cells, which led 
to selective recruitment of T cells, and NK cells [193]. In mice, invariant NKT cells have 
been shown to express multiple chemokine receptors, including CCR7, CXCR3, CXCR6, 
CCR4 and CCR6 [194]. Among these chemokine receptors CCR4 alone was important for 
pulmonary localization [195]. Human NKT cells also express multiple chemokine 
receptors, including CXCR6, CCR1, and CCR6 [196] but it is not known how the 
expression of these chemokine receptors may change in the face of infections. Further, in 
vivo studies with mice have shown that CCL28 promotes recruitment of CCR10-expressing 
IgA plasma cells to lactating mammary glands, where an upregulation of CCL28 
transcription was observed [197] . Similarly, in healthy cattle, CCL28 and CCR10 gene 
expression was shown to be concurrently upregulated in mucosal tissues including 
mammary glands, parotid and mandibular salivary glands, and the small and large 
intestine, which suggests that B-lymphocytes are constitutively recruited to bovine mucosal 
tissues [198]. Multiple chemokines have been shown to direct bovine NK cell recruitment 
including the inflammatory chemokines CCL3, CCL4, CCL5, CCL20 and CXCL8, which 
are secreted by Mycobacterium bovis-infected dendritic cells [199]. Bovine CD335+CD2+ 
NK-cells express multiple chemokine receptors including CCR1, CCR8, CXCR6 and 
CX3CR1. In contrast, bovine CD335+CD2- NK cells express CCR2, CCR5, CCR6, CCR7, 
CXCR3, CXCR4 and CXCR5 and have been shown by in vitro chemotaxis assay to 
migrate in response to relevant chemokines [199]. These studies have shown that multiple 
chemokines can play a role in the recruitment of lymphocytes. Furthermore, bovine γδT-
cells and CD4+ T-cells homing to skin have been reported to express CCR4 and CCR10 
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genes but the expression of the relevant ligands, CCL27 and CCL28, has yet to be 
determined for skin [200].  
The lack of mAbs reacting with bovine chemokines and receptors has limited current 
knowledge in this area to a few transcriptional studies. Future development of specific 
mAbs reacting with bovine chemokines and chemokine receptors will enhance the study of 
leukocyte recruitment in the presence and absence of infection and may provide insight for 
the development of therapeutic tools to modulate inflammatory responses during infection 
and prevent immunopathology. 
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CHAPTER 2: STUDY RATIONALE, HYPOTHESIS AND OBJECTIVES  
 
2.1 RATIONALE 
 
Primary Bovine herpesvirus-1 respiratory infection of cattle is an economically costly 
disease that is prevalent in Canada and worldwide. Multiple generations and types of 
BHV-1 vaccines have been developed and are used commercially but an ideal vaccine, 
which does not result in adverse events following immunization or does not establish a 
latent infection in the host, is not available. Killed viral vaccines or recombinant protein 
vaccines have been developed but they often provide limited protection from disease and 
do not induce long-term immune memory.  
 
Furthermore, BHV-1 can cause abortions in pregnant cows and is a member of the Bovine 
Respiratory Disease Complex (BRDC), which causes fatal respiratory disease in young 
calves. BRDC includes multiple bovine viruses such as BHV-1 and BVDV, and bacteria, 
such as Mannheimia haemolytica and Pasteurella multocida.'These pathogens interact and 
a virus-bacterial synergy that increases the severity of bacterial infections is commonly 
initiated by a primary BHV-1 respiratory infection. The prevention or rapid clearance of a 
BHV-1 respiratory infection is therefore important for the prevention of BRDC infections.  
 
Decades of research related to BHV-1 infection has shown that humoral and cell-mediated 
immune responses are important for recovery from a primary BHV-1 infection. However, 
the immune mechanisms mediating early control of BHV-1 infection are still unknown. 
Further, although cell-mediated responses have been shown in vitro to be a component of 
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host responses to BHV-1 infection, the phenotype of the lymphocytes recruited to mucosal 
sites of a primary BHV-1 infection have yet to be determined.   
 
2.2 HYPOTHESES: 
1. BHV-1 is a potent inducer of IFN-α and –γ in the upper respiratory tract but IFN-induced 
antiviral effector mechanisms are not the primary mechanism limiting BHV-1 replication 
during an acute respiratory infection. 
 
2. Innate lymphocytes recruited to the upper respiratory tract during an acute BHV-1 
respiratory infection may provide an important effector mechanism for the control of viral 
infection 
 
2.3 OBJECTIVE 
The overall objective of this project was to identify innate mechanisms involved in the 
clearance of a primary Bovine herpesvirus-1 infection. To address this objective, we set out 
the following aims: 
 
SPECIFIC AIMS: 
1. Confirm that during an experimental BHV-1 infection of the bovine URT there was 
induction of type I and II IFNs, and relate the IFN response to virus replication in the URT. 
2. Investigate the induction of interferon-induced antiviral effector genes during the primary 
BHV-1 infection in the URT of calves. 
3. Analyze the direct antiviral effects of bovine type 1 and 2 interferons on BHV-1 replication 
in vitro, and induction of ISGs in bovine epithelial cells by bovine Type 1 and 2 
interferons. 
4. Analyze the phenotype and frequency of specific lymphocyte subpopulations recruited to 
nasal turbinates and trachea following a primary BHV-1 infection in calves. 5. Analyze gene expression of chemokines in BHV-1 infected tissues to determine whether 
specific chemokines may be implicated in the recruitment of specific lymphocyte 
subpopulations to the site of BHV-1 infection.!
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CHAPTER 3: INDUCTION OF INTERFERON AND INTERFERON-INDUCED 
ANTIVIRAL EFFECTOR GENES FOLLOWING A PRIMARY BOVINE HERPES 
VIRUS -1 (BHV-1) RESPIRATORY INFECTION 
 
This chapter has been published in Journal of General Virology as: Osman R, Gonzalez-
Cano P, Brownlie R, Griebel PJ. Induction of interferon and interferon-induced antiviral 
effector genes following a primary bovine herpesvirus-1 (BHV-1) respiratory infection. J 
Gen Virol. 2017 Jul;98(7):1831-1842.  
I was responsible for conception, design of the studies and writing the manuscript. I also 
designed and validated primers, performed experiments, and analyzed the data.  
   
 
Relevance of this study to the Thesis 
These studies address questions posed within the first hypothesis of this thesis. 
The induction and secretion of type I and II interferons and the transcription of interferon-
induced antiviral effector genes were analyzed during a primary BHV-1 infection of the 
bovine upper respiratory tract.  
  
3.1 Abstract 
In vitro investigations have identified a variety of mechanisms by which 
herpesviruses evade interferon-stimulated antiviral effector mechanisms. However, these 
immune evasion mechanisms have not been evaluated during a bovine herpesvirus-1 
(BHV-1) infection. This study investigated transcription and secretion of type I and II IFNs 
and transcription of IFN-stimulated genes (ISGs) during a primary BHV-1 infection of the 
upper respiratory tract (URT) in naïve calves. IFN-α, -β, and -γ transcription in nasal 
turbinates and protein levels in nasal secretions increased following infection. Increased 
IFN type I and II secretion was detected 3 days post-infection (pi) and IFN production 
increased in parallel with virus shedding.  Expression of ISGs, including Mx1, OAS and 
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BST-2, also increased significantly (P < 0.05) in nasal turbinates on day 3 pi and elevated 
ISG expression persisted throughout the period of viral shedding. In contrast, RNAase L 
gene expression was not induced during the BHV-1 infection in the nasal turbinates but 
was induced on Day 10 pi in the trachea.  In vitro studies confirmed that recombinant 
bovine (rBo)IFN-α, β and -γ induced expression of Mx1, OAS, and BST-2 but decreased 
RNAse L transcript in bovine epithelial cells. Relative to Vesicular Stomatitis Virus (VSV), 
BHV-1 was resistant to the antiviral activity of rBoIFN-α and –γ, but treatment of 
epithelial cells with 10 ng rBoIFNβ/ml effected an 80% inhibition of BHV-1 replication 
and complete inhibition of VSV replication. These observations confirm that transcription 
and translation of type I and II IFNs increase during BHV-1 infection, and transcription of 
some ISGs was not inhibited.  
 
3.2 Introduction 
Interferons (IFN) are a diverse family of proteins that function as an important 
component of the innate immune defense against viral infections. There are three major 
types of IFNs, Type I, II, and III, known to have antiviral activity. Type I bovine IFNs 
include 9 subtypes of IFN-α and 3 subtypes of IFN-β [76]. Bovine type II IFN comprises 
only IFN-γ, encoded by a single gene [201] and Type III bovine IFN is currently 
represented by IFN-λ3 [202]. IFNs act in a biphasic manner, with increased IFN 
production activating IFN signaling pathways. IFN production is induced following 
detection of viral components by pattern recognition receptors (PRR), such as Toll-like 
receptors (TLRs). Both type I and II IFNs are known to establish an “antiviral state” when 
bound to appropriate cell surface receptors prior to viral infection [203].This antiviral state 
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involves activation of interferon-stimulated genes (ISG) and subsequent production of 
antiviral effector proteins, including double-stranded RNA-dependent protein kinase R 
(PKR), Myxovirus resistance (Mx) proteins, oligoadenylate synthetase-RNAase L (OAS-
RNAse L) and BST-2 or Tetherin [204] . These antiviral effector proteins target different 
steps in the viral replication cycle to prevent both assembly and release of infectious virus 
particles [204]. It is not known, however, if both type I and II bovine IFNs activate similar 
ISGs and anti-viral effector proteins.  
 
Bovine Herpes Virus-1 (BHV-1) is a member of the subfamily, 
Alphaherpesvirinae, characterized by lytic infection of epithelial cells at mucosal surfaces 
and the establishment of latent infections in peripheral sensory neurons [205].  BHV-1 was 
first described in 1928 as the cause of a venereal disease in cattle known as 
“Bläschenausschlag” by Reisinger and Reimann [206]. A respiratory form of BHV-1 
infection was later discovered in 1953 and described as infection of the upper respiratory 
tract and named Infectious Bovine Rhinotracheitis (IBR) [36]. Primary BHV-1 respiratory 
infections may last 10 to 12 days, and bovine nasal turbinates, pharyngeal tonsils, and 
trachea are the primary sites of infection in the upper respiratory tract (URT) [61]. BHV-1 
is a potent inducer of type I and II bovine interferons [67, 81, 82] and there is evidence that 
BHV-1 evades both type I and II IFN-induced antiviral effector mechanisms. Pre-treatment 
of calves with recombinant bovine IFN-α1 did not significantly reduce virus shedding 
following an experimental BHV-1 challenge [81] and expression of bovine IFN-γ by a 
recombinant BHV-1 did not significantly reduce viral replication [82].  Previous studies 
have confirmed induction of ISGs, such as OAS, in blood leukocytes following BHV-1 
! 50!
infection [67], but no studies have evaluated the expression of ISGs at the site of viral 
infection in the URT.  Thus, it is not known whether local production of type I and II IFNs 
results in increased ISG expression at the site of viral infection and whether the onset of 
ISG expression coincides with a decline in viral replication. 
The mechanism(s) by which BHV-1 may evade IFN antiviral activity has been 
investigated in vitro. BHV-1 immediate early protein, bovine ICP0 (bICP0) was reported 
to induce degradation of IRF-3, resulting in decreased IFN-β transcription [84]. Similarly, 
bICP0 may also inhibit intermediate kinases in the interferon-signalling pathway, including 
TANK- binding kinase 1 (TBK1) and IκB kinase epsilon (IKKε), resulting in an inhibition 
of IFN-β promoter activity and decreased ISG expression [85]. Another in vitro study 
reported that an immediate early BHV-1 protein, bICP27, inhibits the activity of the 
promoters of bovine IFN-β resulting in an inhibition of IFN-β transcription [83]. Other 
IFN evasion mechanisms have been identified for members of the Alphaherpesvirinae 
subfamily, such as Herpes simplex-1 (HSV-1). HSV-1 encodes gene products that block 
IFN-α production and inhibit the antiviral activity of PKR through dephosphorylation of 
eIF-2 [86]. Varicella Zoster Virus (VZV) also inhibits PKR through phosphorylation of 
eIF-2α [87]. Additionally, HSV-1 has been shown to block BST-2 function through Virion 
Host Shut off protein (Vhs)- mediated degradation of BST-2 mRNA[207]. Thus, in vitro 
studies provide evidence that Herpesviruses may inhibit transcription of IFN genes and 
inhibit IFN-induced antiviral effector proteins at both a transcriptional and post-
transcriptional level. It has not been determined in vivo, however, whether BHV-1 evades 
the IFN response through an inhibition of IFN transcription or translation or through an 
inhibition of ISGs at a pre- or post-transcriptional level. 
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In this paper, we confirm that BHV-1 infection induces transcription and secretion 
of both IFN-α and –γ in the URT, and for the first time also demonstrate coincidental 
transcription and secretion of IFN- β. Production of both types I and II IFNs in the upper 
respiratory tract preceded peak levels of virus shedding in nasal secretions. To further test 
the hypothesis that BHV-1 evades IFN antiviral activity through an inhibition of ISG 
transcription, we also analyzed ISG transcription in URT tissues. This analysis supports the 
conclusion that BHV-1 evasion of IFN, a key innate immune defence, does not occur 
through an inhibition of either the transcription or translation of IFNs or a transcriptional 
inhibition of ISGs.  
 
3.3 Methods and Materials 
3.3.1 Animals: 
Female and castrated male, 5 to 6 month old, crossbred (Angus X Hereford), suckling 
calves (n=30) were purchased from a single commercial herd. Calves were identified as 
seronegative for BHV-1 by screening with a recombinant, truncated glycoprotein D (tgD) 
antibody capture ELISA [208]. For this study, calves were weaned, transported to the 
VIDO research facility, and adapted for 2 weeks to a diet of free choice hay and 0.5 kg 
oats/day.  Calves were housed in a single pen.  The average weight of calves was 232 kg 
with body weights ranging between 174 and 242 kg. Tissue samples were collected from 
nasal turbinates and trachea of 6 animals on Days 0 (pre-infection), 3, 5, 7, and 10 post-
infection (pi).  All experiments were conducted according to the Guide to the Care and Use 
of Experimental Animals, provided by the Canadian Council on Animal Care and the 
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experimental protocol was approved by the University of Saskatchewan Animal Care 
Committee.  
 
3.3.2 Experimental Infection and Sample Collection: 
All calves were aerosol challenged with BHV-1 isolate 108 (5 X 107pfu/animal) on 
Experimental Day 0 as previously described [67]. A clinical veterinarian, blinded to 
treatment group, examined calves daily and recorded body weight and temperature. Nasal 
swabs for the analysis of virus shedding and nasal secretions for the analysis of IFN were 
collected from all animals prior to BHV-1 challenge and on day 3, 5, 7, and 10 post-
infection (pi). Nasal secretions for quantifying virus shedding were collected with sterile 
cotton swabs, which were then immersed in 1 ml of Minimum Essential Medium (MEM) 
and transported on ice to the lab. Swabs were stored at -20oC prior to performing viral 
plaque assays to quantify infectious BHV-1 particles. Nasal secretions for assaying IFN 
secretion were collected by inserting a cotton tampon into the ventral meatus of the nostril 
for 20 minutes. The absorbed fluid was expressed from the tampon and stored at -80oC 
until analyzed by ELISA. For tissue collection, cohorts of 6 calves were euthanized with an 
intravenous injection of Euthanyl (240 mg/ml; Bimeda-MTC, Canada) on Days 0, 3, 5 7, 
and 10 pi, immediately following the collection of nasal swabs for virus and nasal 
secretions for IFN analysis. Tissue samples were collected within 15-20 minutes after 
euthanasia and three replicate samples were immediately placed in RNAlater or 10% 
buffered formalin. Tissue samples from nasal turbinates were collected 10-12 cm from the 
external nares and tracheal mucosa was collected from the mid-trachea region of all calves. 
Formalin-fixed tissues were used for histology and immunohistochemical detection of 
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BHV-1. Tissues fixed with RNAlater were stored at -80oC until RNA was extracted for 
qRT-PCR analysis of transcripts from IFN genes and ISGs.  
 
3.3.3 Enzyme-Linked Immunosorbent Assay (ELISA):  
Calves were screened for BHV-1-specific serum antibodies using an antibody-capture 
ELISA as previously described [209]. Briefly, recombinant BHV-1 truncated glycoprotein 
D (tgD) was used to coat ELISA plates for antibody capture following serial dilution of 
serum samples. Calves with serum antibody titres less than 1/100 were considered 
seronegative. IFN-α and -γ concentrations in nasal secretions were quantified by ELISA as 
previously described [82]. The IFN-α ELISA used in this study used a capture monoclonal 
antibody raised against the BoIFN-αI1 protein expressed from the cloned sequence of the 
BoIFN-αI1 gene shown in Supplemental Figure A [210]. IFN-β concentrations in nasal 
secretions were determined using a commercial bovine IFN-β ELISA kit (Biomatik), 
following the manufacturer’s instructions. 
 
3.3.4 Cells and Viruses: 
A bovine mucosal epithelial cell line was established from fetal bovine intestine [209] and 
Madin-Darby bovine kidney (MDBK) cells were purchased from ATCC (ATCC # CCL22). 
The mucosal epithelial cells were cultured in DMEM with 5% FBS, 5µg/ml of Apo-
transferin (Sigma), 0.025µg/ml of Epidermal Growth Factor (EGF) (Sigma), 0.1µg/ml of 
Hydrocortisone (Sigma), 10µg/ml of insulin (Sigma), and 50µg/ml Gentamicin (Gibco) per 
500 ml Dulbecco's Modified Eagle Medium (DMEM).  MDBK cells were cultured as 
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previously described [211]. The BHV-1 isolates used were 108, (Animal Disease Research 
Institute, Lethbridge, AB) and Cooper strain (ATCC# VR864).  Vesicular Stomatitis Virus 
(ATCC# VR158) was used as a positive control when quantifying the antiviral activity of 
recombinant bovine (rBo) IFN-α, β and -γ.  
 
3.3.5 BHV-1 Plaque Assay 
MDBK cells were used to perform a plaque assay to quantify infectious BHV-1 shed in 
nasal secretions as described previously [211, 212].   
 
3.3.6 Immunohistochemical (IHC) staining of bovine tissues for BHV-1 proteins 
Tissues from the nasal turbinates, pharyngeal tonsils, and trachea were collected from 6 
animals euthanized prior to BHV-1 infection and 6 animals each on days 3, 5, 7, and 10 pi. 
Tissues were fixed in 10% buffered formalin (HARLECO) prior to embedding in paraffin 
and 5 µm tissue sections were cut, treated for antigen recovery, and then stained with a 
polyclonal rabbit anti-BHV-1 antisera (Prairie Diagnostic Services [PDS], Saskatoon, SK).  
 
3.3.7 RNA Extraction  
The TRIzol method (Invitrogen), as described previously [8], was used to extract total 
RNA from nasal turbinates and trachea samples stabilized in RNAlater®. RNA was 
extracted from one million cultured mucosal epithelial cells seeded per well in CellBind 6-
well plates (Corning). Cells were stimulated with 100 ng/ml of either rBoIFN-α, -β, or -γ 
for the indicated time intervals (Fig. 3.5). At each time point, culture supernatant was 
removed and one millilitre of TRIzol was added to each well, gently pipetted up and down 
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to lyse cells and the lysate was stored at -20o C until RNA was extracted.  RNA extraction 
was performed as described previously [8].  RNA quality and total RNA were determined 
using the Agilent 2100 Bioanalyzer (Agilent Technologies). Samples with an RNA 
Integrity Number (RIN) of 7 or higher were used to prepare cDNA. 
 
3.3.8 cDNA synthesis and quantitative real-time PCR (qRT-PCR) 
Total RNA (1µg) was reverse-transcribed using qScript™ cDNA SuperMix (Quanta 
Biosciences™), following the manufacturer’s protocol. cDNA samples were diluted in 
DNAse/RNAse free water for use as template in qRT-PCR reactions.  
 
3.3.9 qRT-PCR primer design and validation 
Primer pairs for interferon-stimulated gene (ISG) transcripts (Table 1) were designed using 
DNAMAN software (Lynnon Corp, Quebec) and primers for IFN-α, β and -γ transcripts 
were designed using Clone Manager 9.0 program (Sci-Ed Software).  Primers for IFN-α, -
β and -γ transcripts were designed to validate IFN-α, β and -γ protein levels detected by 
ELISA.  The BoIFN-αI1 [210] nucleotide sequence  was identified to be 99% homologous 
(Supplemental Fig. 3A (i)) to BoIFN-α-D and specific primers were designed for  BoIFN-
α-D.  Sequences have been reported for 8 subtypes of bovine IFN-α and three subtypes of 
IFN-β [76]. Despite high homology among IFN-β subtypes (Supplemental Fig. 3B (ii)), 
there exist single nucleotide polymorphisms (SNPs) among the subtypes.  To detect 
transcripts from all IFN-β subtypes, primer pairs designed for IFN-β genes were designed 
with IUPAC nucleotides whereby 50% of the primer(s) contains one nucleotide while the 
other 50% contains a different nucleotide at the same position (Table 3.1). Primer 
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specificity for individual IFN genes was confirmed through generation of a single peak in 
the melting curve and detecting a single band of expected size following gel 
electrophoresis of PCR products. Additionally, the IFNα and –β PCR products were 
cloned in the PCR 2.1 vector using the TA cloning kit (Invitrogen). Cloned PCR products 
were sequenced with a CEQ 200XL DNA Analysis system (Beckman Coulter) to confirm 
product identity and size.  Sequencing of cloned IFN-β PCR products, IFN-β Clone A and 
B, identified the products as IFN-β2 and IFN-β1 (Supplemental Fig. 3A (iii) and (iv)), 
respectively, confirming that the primers identified multiple IFN-β subtypes. One BoIFN-
α-D PCR product was cloned and sequenced and confirmed to be 99% homologous to 
BoIFN-α-D (Supplemental Figure 3A (ii)). Primer amplification efficiency was also 
determined by performing a standard curve as described previously [213].  
 
 
3.3.10 qRT-PCR Analysis of ISG and IFN-α , IFN-β , and -γ  Gene Expression: 
Gene expression data for individual samples was normalized relative to β-actin, which was 
previously validated as suitable reference gene in bovine mucosal epithelial cells [214]. We 
also confirmed that expression of the reference gene did not change significantly over time. 
qRT-PCR was performed using the PerfeCTa® SYBR® Green FastMix for iQ (Quanta 
BioScience). Briefly, 9 µl of PerfeCTa® SYBR green master mix (2X), 3 µL of the primer 
pair at 3.3 µM, and 3 µL cDNA template were added to a 15 µL final volume. The reaction 
was performed in BioRad iCycler iQ PCR detection system using the following program: 1 
cycle at 95 °C for 30 sec, 45 cycles of 95 °C for 15 sec, 60 °C for 30 sec and 72 °C for 30 
sec. After the cycling, the temperature was increased starting from 56 °C at a rate of 1 °C 
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every 10 sec to build a melting curve (40 times). Amplification data obtained for individual 
genes was expressed as threshold cycle (Ct) and was subtracted from the Ct of the β-actin 
reference gene to obtain ΔCt (ΔCt = Ct gene – Ct β-actin).  Fold-change was calculated by 
using the formula; 
Fold change = 2-ΔΔCt 
ΔΔCt is calculated by subtracting ΔCt value of the control (untreated or uninfected sample) 
from the time- matched ΔCt value for the experimental group (treated or infected) [215]  
 
3.3.11 Interferon Plaque-Inhibition Assay: 
Monolayers of mucosal epithelial cells were prepared by seeding 12-well CellBind plates 
(VWR) with 2.5 x 104 cells/well. Cultures were 70-80% confluent within 3h of seeding and 
duplicate wells were then treated with IFN-α, -β and -γ doses ranging from 0.01 – 10,000 
ng/ml. Duplicate wells without IFN treatment were infected with BHV-1 and used as 
positive controls for virus plaque-forming units (pfu). Confluent bovine mucosal epithelial 
cell cultures were incubated with the indicated type and concentration of interferon for 12 
h before medium was aspirated. Fifty pfu BHV-1 (108) or VSV in 0.5ml serum-free 
DMEM were added to each well for 1h before overlaying the monolayer with bovine anti-
BHV-1 antisera for BHV-1 infected cultures or 1% methylcellulose in complete media for 
VSV infected cultures. Cultures were then incubated at 37o C for 40-45 hour before using 
80% methanol and 0.5% Crystal Violet in to fix and stain cells.  Viral plaques were 
enumerated under an inverted microscope. 
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3.3.12 Statistical Analysis: 
Data were analyzed using GraphPad software (Version 7.0a). Virus shedding by infected 
calves was analyzed using a 2-way ANOVA to analyze the effect of days post-infection on 
BHV-1 shedding. A Mann-Whitney test was used to compare levels of IFNα , β or -γ  
detected in nasal secretions and nasal turbinate tissues following BHV-1 infection relative 
to uninfected tissues from Day 0.  The student t-test was used to compare IFN inhibition of 
BHV-1 and VSV viral plaques. A Mann-Whitney test was used to analyze changes in the 
expression level of individual ISG in infected nasal turbinate and tracheal tissues relative to 
the uninfected controls. 
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Table 3.1. Primers For Amplification Of Bovine IFNs and ISGs 
 
Gene 
  
Primer Sequence* 
Product 
size 
(bp)§ 
Primer 
efficienc
y‡ 
mx1 FWD AGATGTCCTGTCTAGATCCC 127 2.1 
 RV GGCAAAGTCAGCTTCCTGG   
Oas FWD TCACAGAGTTCGGGTGTCC 160 2.1 
 RV CCTGATTTCTTCGATGAATTCT   
Rnasel FWD ATTGTGCCTCCTCATACTGG 111 2.1 
 RV TGTTATGGCTCTCAGTCTCC   
bst-2 FWD TGCTTGTGCCCATGATCTAC 190 2 
 RV TCCCTCAGGGTCACCATAG   
IFN –α FWD ACACACACCTGGTTCAACAC 96 1.97 
 RV GATGACAGCAGAAATGAGTCTTCC   
IFN-β FWD RTCTGSAGCCAATCCARAAG 136 1.98 
 RV CAGGCACACCTGTYGTACTC   
IFN-γ FWD TGCAGATCCAGCGCAAAGC 122 2.03 
 RV CGTTGATGCTCTCCGGCC   
* Sequence of forward (FWD) and reverse (RV) primers;  
§Size of amplified PCR product;  
‡Efficiency of product amplification 
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3.4 Results  
 
3.4.1 Virus shedding persists after induction of IFN secretion  
BHV-1 shedding in nasal secretions of infected calves increased significantly 
(P=0.002) by Day 3 pi to a mean value exceeding one million pfu/ml of nasal secretion and 
remained at this level until Day 7 pi (Fig. 3.1a). Virus shedding then decreased 
approximately three logs on Day 10 pi to a mean value of approximately 1000 pfu/ml.  
IHC staining of tissues collected from the URT with rabbit anti-BHV-1 antisera 
revealed a similar temporal pattern for virus replication (Fig. 3.1b). No visible staining for 
BHV-1 was observed in any of the tissues prior to BHV-1 infection (Fig. 3.1b). In contrast, 
nasopharyngeal tonsils from all animals (n = 6) had visible focal staining of epithelial cell 
for BHV-1 on days 3 and 5 pi but detectable staining then decreased to approximately 70% 
(4/6 animals) on day 7 pi and 50% (3/6 animals) on day 10 pi. A similar focal staining 
pattern was observed with nasal turbinates but visible staining was detected in tissue 
samples from all 6 animals only on day 5 pi (Fig. 3.1b). The frequency of animals with 
detectable staining for BHV-1 in tracheal tissue was much lower at all time points, with 
only 4 of 6 animals having visible foci on Day 3 pi and 50% of animals (3/6) positive on 
Days 5 and 7 pi (Fig. 3.1b) These observations support the conclusion that shedding of 
infectious BHV-1 in nasal secretions correlates with virus replication in URT tissues. 
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Figure 3.1. Viral replication in the upper respiratory tract following a primary BHV-
1 infection. (a) Shedding of infectious BHV-1 particles in nasal secretions. Virus titres were 
determined by plaque assay and data presented are values for individual animals (n = 6/time point). 
(b) BHV-1 infection of nasal turbinate, nasopharyngeal tonsil, and tracheal mucosa was detected by 
IHC using a polyclonal rabbit anti-BHV-1 antisera. Data presented are the number of individual 
animals (n = 6/time point) from which tissue samples had detectable positive staining of BHV-1 
antigens in mucosal epithelial cells.   
 
Immunohistochemical staining of nasal turbinates revealed that BHV-1 replication 
occurred within discrete foci and was restricted primarily to the mucosal epithelial layer. 
The normal epithelial architecture of nasal turbinates is characterized by a pseudostratified 
columnar epithelium separated from the underlying lamina propria by a visible basement 
membrane (Fig. 3.2a). IHC staining with rabbit anti-BHV-1 antisera confirmed there was 
no visible staining of nasal turbinates (Fig. 3.2c) or nasopharyngeal tonsil (data not shown) 
collected on day 0, prior to BHV-1 infection. In contrast, IHC staining of tissue sections 
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collected following BHV-1 infection revealed infected foci within the mucosal epithelial 
layer, characterized by extensive disruption of normal tissue architecture and loss of 
epithelial cells (Fig. 3.2d). Staining for BHV-1 antigens was most intense in epithelial cells 
at the margins of these infected foci and there was no visible staining of adjacent mucosal 
epithelium. Thus, high levels of infectious viral particles in nasal secretions on days 3 to 7 
pi did not result in a uniform infection of mucosal epithelial cells within the nasal 
turbinates or trachea but there was extensive loss of epithelium overlying the 
nasaopharyngeal tonsils (data not shown). This observation is important when considering 
qRT-PCR results for tissue samples collected from nasal turbinates since these samples 
included both BHV-1 infected and uninfected epithelial cells.  
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Figure 3.2. BHV-1 infection of mucosal epithelial cells in nasal turbinates. Mucosal 
tissue architecture was examined before and after primary BHV-1 infection. Tissue samples for 
histology were collected from the same animals used to quantify virus shedding in Figure 1. Nasal 
turbinate samples were collected in 10% buffered formalin on Day 0, prior to BHV-1 infection (a) 
and on Day 5 post-infection (b) and tissue sections were stained with haematoxylin and eosin 
(H&E). Serial tissue sections cut from the tissue blocks prepared for Day 0 (c) and Day 5 post-
BHV-1 infection (d) were stained with polyclonal rabbit anti-BHV-1 antisera  to visualize foci of 
BHV-1 infection. Small arrows indicate BHV-1 infected cells. GL = Glands, ME = Mucosal 
Epithelium, CI = Cell Infiltration.  BM = Basement Membrane, LP = Lamina Propria. 
 
High levels of infectious BHV-1 in nasal secretions on Day 3 pi coincided with a 
significant (P˂ 0.01) increase in IFN-α secretion (Figure 3.3a). Peak IFN-α levels were 
detected on Day 5 pi. IFN-α secretion declined significantly on Day 7 pi, even though 
virus shedding persisted at a high level. Thus, onset of IFN-α production in nasal 
secretions did not correlate with a decline in virus shedding and peak IFN-α levels did not 
coincide with a decline in virus production.  
The commercial ELISA used to quantify bovine IFN-β in nasal secretions gave 
optical density reading consistent with IFN-β being present prior to viral infection (Fig. 
3.3b).  There was, however, a significant (P < 0.05) increase in IFN-β levels in nasal 
secretions on Day 5 pi (Fig. 3.3b). A high level of BHV-1 shedding was, therefore, 
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observed both before and after peak IFN-β production. Finally, a significant (P < 0.0001) 
increase in IFN-γ production was detected in nasal secretions on Day 3, 5 and 7 pi (Fig. 
3.3c). Therefore, a high level of virus shedding persisted for at least 2 days after maximum 
levels of IFN-α, -β and -γ were detected in nasal secretions.  
IFN levels in nasal secretions may not correlate directly with cytokine production 
within tissues. Therefore, qRT-PCR analysis of IFN gene expression in nasal turbinates 
was completed to determine whether IFN protein levels in nasal secretions reflected host 
responses at the site of viral infection. There was marked inter-animal variability in IFN-α 
transcript abundance when analyzing nasal turbinates collected prior to BHV-1 (Fig. 3.3d). 
Following BHV-1 infection, there was a consistent decrease in median ΔCt values of IFN-
α transcript but this change was significant (P < 0.05) only on Day 7 pi. While protein 
levels in nasal secretions did not directly mirror IFN-α transcript abundance in nasal 
turbinates, the qRT-PCR analysis confirmed that IFN-α transcript increased early after 
viral infection. Furthermore, peak IFN-α and β transcript abundance and secretion both 
occurred during the period of peak virus shedding. 
The qRT-PCR analysis also confirmed an early increase of IFNβ transcription following 
BHV-1 infection with significantly (P < 0.05) increased transcript abundance on days 3, 5 
and 7 pi (Fig. 3.3e). IFNβ gene transcript abundance then declined on day 10 pi but did not 
return to pre-infection levels. Thus, qRT-PCR analysis revealed an early and sustained 
increase in transcript abundance for IFNβ genes in BHV-1 infected tissue, but increased 
transcription of IFNβ genes was not closely associated with a decrease in virus shedding.  
The abundance of IFN-γ gene transcript also varied widely among individual 
animals prior to BHV-1 infection. High intra-group variance limited the capacity to detect 
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significant changes in transcript abundance when analyzing 6 animals/time point. There 
was, however, a consistent decrease in median ΔCt values for IFN-γ gene transcript on all 
days analyzed following BHV-1 infection (Fig. 3.3f).  This decrease in ΔCt values was 
maximum on day 5 pi, coinciding with maximum IFN-γ protein levels in nasal secretions 
(Fig. 3.3c). Thus, qRT-PCR results were consistent with ELISA data (Fig. 3.3c).  
 
 
Figure 3.3. IFN secretion in nasal secretions and IFN gene expression in nasal 
turbinates following primary BHV-1 respiratory infection.  The concentration of 
IFN-α (a), IFN-β (b) and IFN-γ (c) in nasal secretions was determined with cytokine capture 
ELISAs. Nasal secretions were collected from animals (n = 6/time point) just prior to euthanasia 
and collection of tissue samples for the analysis of IFN gene expression. Data presented are the 
median and interquartile range of values for each cohort of animals.  qRT-PCR analysis of IFN-α 
(d),  IFN-β (e), and IFN-γ (f) gene expression was performed using primers that amplified multiple 
bovine IFN-α and all three known bovine IFN-β genes. Data are presented as ΔCt values relative to 
the β-actin gene and values for individual animals are presented. The horizontal bar represents the 
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median value at each time point. Significant changes in IFN protein levels or IFN gene expression 
relative to Day 0 are indicated: *P < 0.05; **P < 0.01; ***P < 0.001 and P ≤ 0.0001. 
 
3.4.2 Expression of antiviral effector genes in nasal turbinates  
Monitoring expression of known antiviral effector genes provides an independent 
confirmation that biologically active levels of IFN were present in infected tissues. qRT-
PCR analysis revealed a highly significant (P < 0.001) increase in both OAS (Fig. 3.4a) and 
Mx1 (Fig. 3.4b) transcripts within 3 days pi and this increase persisted throughout viral 
infection.  A similar expression pattern was observed for BST-2 (Fig. 3.4c), with a 
significant (P < 0.01) increase in BST-2 transcript on days 3, 5 and 7 pi and a decline in  
transcript abundance on day 10 pi. In contrast, RNAseL transcript abundance (Fig. 3.4d) 
was significantly (P < 0.001) decreased on days 5 and 7 pi but approached pre-infection 
levels on days 10 pi.   
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Figure 3.4. Interferon-induced antiviral effector gene expression in nasal 
turbinate tissue samples collected before and following BHV-1 infection.  
qRT-PCR was used to quantify gene expression of 2’5’oligoadenylatesynthetase (OAS) (a) 
Myxovirus resistance 1 (Mx1) (b), Bone Marrow Stromal Cell Antigen 2 (BST-2) (c) and 
Ribonuclease L (RNAse L) (d) genes. Data are presented as ΔCt values relative to the β-actin gene 
and presented as median and interquartile range of values for tissue collected from 6 animals at 
each time point. Significant changes in gene expression relative to Day 0 are indicated: *P < 0.05; 
**P < 0.01; ***P < 0.001 and P ≤ 0.0001. 
 
3.4.3 Expression of antiviral effector genes in trachea  
Transcription of IFN-induced antiviral effector genes was also analyzed for tracheal tissue 
samples. A significant (P < 0.05) increase in OAS (Fig. 3.5a) and Mx1 (Fig. 3.5b) 
transcripts was observed within 3 days pi with sustained increase throughout the period of 
viral infection. A significant increase in BST-2 transcript level was not detected until Day 
10 pi (Fig. 5c). As observed with nasal turbinates, there was a significant (P < 0.05) 
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decrease in RNAse L transcript on days 3 to 7 pi but this was reversed on day 10 pi when 
transcript abundance was significantly (p < 0.01) increased.  
Thus, increased transcription of multiple ISGs was detected within 3 days pi for 
both nasal turbinates and trachea. While there were tissue-specific differences in ISG 
transcriptional responses, we consistently observed that the onset of increased ISG 
expression was not associated with a decline in virus shedding (Fig. 3.1a) or tissue 
infection (Fig 3.1b).  
 
 
Figure 3.5. Interferon-induced antiviral effector gene expression in tracheal 
tissue samples collected before and following BHV-1 infection. qRT-PCR was used 
to quantify gene expression of 2’5’oligoadenylatesynthetase (OAS) (a) Myxovirus resistance 1 
(Mx1) (b), Bone Marrow Stromal Cell Antigen 2 (BST-2) (c) and Ribonuclease L (RNAse L) (d) 
genes. Data are presented as ΔCt values relative to the β-actin gene and presented as median and 
interquartile range of values for tissue collected from 6 animals at each time point. Significant 
changes in gene expression relative to Day 0 are indicated: *P < 0.05; **P < 0.01; ***P < 0.001 
and P ≤ 0.0001. 
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3.4.4 IFN induction of antiviral effector genes in bovine epithelial cell 
qRT-PCR analysis revealed a significant induction of three of four IFN-induced effector 
genes analyzed in nasal turbinate samples following BHV-1 infection. Coincidental 
production of multiple IFN types (Fig. 3.3) suggested that more than one IFN type may be 
responsible for the observed increases in ISG transcripts. There is limited information 
regarding bovine ISG responses to IFN-α [216], and little is known regarding the induction 
of ISGs by bovine IFN-β and -γ.  Therefore, we investigated whether rBoIFN-α , -β and –γ 
have the capacity to induce expression of the four antiviral effector genes analyzed 
following BHV-1 infection. Mx1, OAS, and BST-2 transcription increased 10- to 100-fold 
within 4 hours after bovine epithelial cells were exposed to rBoIFN-α and remained 
elevated for 12 hours (Fig 3.6a). Similarly, Mx1, OAS, and BST-2 transcription increased 
within 4 hours after exposure to 100ng/ml of IFN-β but transcription then decreased to 
basal levels by 6 hours post-treatment (Fig. 3.6b). rBoIFN-γ also induced a sustained 10- to 
100-fold increase Mx1, OAS,  and BST-2 transcription throughout the 12 hour period (Fig. 
3.6c). Both rBoIFN-α and -γ induced increased RNAse L transcription at 4 hours post-
treatment (Fig. 3.6a and 3.6c) but RNAse L transcription was not altered by rBoIFN-β 
treatment (Fig 3.6b). Thus, both type I and II rboIFNs have the capacity to induce 
expression of multiple ISGs in bovine epithelial cells.  
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Figure 3.6. Induction of antiviral effector gene expression in bovine epithelial 
cells following treatment with rBoIFN-α , -β  and -γ . qRT-PCR was used to quantify  
transcript abundance of  Mx1, OAS,  RNAse L  and BST-2 genes induced following treatment with 
100 ng/ml of either rBoIFN-αI  (a) , rBoIFN-β (b), or rBoIFN-γ (c).   Gene expression data are 
expressed as fold change relative to gene expression in time-matched cultures not treated with 
rBoIFN.  
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3.4.5 BHV-1 evasion of IFN antiviral activity  
The persistence of a high level of BHV-1 shedding (Fig. 3.1a) following significant 
induction of IFN-α, -β, and -γ protein and gene expression in nasal turbinates (Fig. 3.3) 
suggested that BHV-1 effectively evades IFN-induced antiviral effector mechanisms. To 
address this possibility, a plaque inhibition assay was used to compare rBoIFN inhibition 
of BHV-1 replication relative to Vesicular Stomatitis Virus (VSV), a virus well-
documented to be sensitive to IFN [217].  A 50% inhibition of VSV pfu was observed 
when cells were pre-treated with 0.005 ng rBoIFN-α/ml and complete inhibition of VSV 
replication was observed following treatment with 1 ng rBoIFN-α/ml (Fig. 3.7a). In 
contrast, rBoIFN-α inhibition of the BHV-1 isolate 108 (Fig. 3.7a) and Cooper isolate 
(data not shown) approached 50% only when cells were pre-treated with 10,000 ng 
rBoIFN-α/ml. This is an IFN-α concentration over 1000-fold higher than that detected in 
nasal secretions from infected animals (Fig. 3.3a). rBoIFN-β also displayed strong antiviral 
activity, with 50% inhibition of VSV pfu following pre-treatment of cells with 0.005 ng 
rBoIFN-β ml and complete inhibition of VSV replication with 10 ng rBoIFN-β ml (Fig. 
3.7b).  rBoIFN-β concentrations of 0.05 ng/ml and 10 ng/ml were able to effect a 50% and 
80% inhibition, respectively, of BHV-1 108 (Fig. 3.7b) and Cooper isolates (data not 
shown). Thus, substantial inhibition of BHV-1 replication was observed with rBoIFN-β 
concentrations similar to those detected in nasal secretions on day 5 pi (Fig. 3.3b). 
rBoIFNγ also displayed substantial antiviral activity with 50% inhibition of VSV pfu when 
cells were pre-treated with 0.01ng rBoIFN-γ/ml and complete inhibition of VSV 
replication with 100 ng rBoIFN-γ/ml (Fig. 3.7c). When comparing the concentration of 
rBoIFN required to completely inhibit VSV replication then rBoIFNγ was 100-fold less 
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active than rBoIFNα and 10-fold less active than rBoIFN-β. Furthermore, the highest 
concentration of rBoIFN-γ tested in vitro, which was 500-fold higher than that detected in 
vivo (Fig. 3.3c), effected less than 30-40% inhibition of BHV-1 isolate 108 (Fig. 3.7c).  
 
Figure 3.7. Inhibition of BHV-1 replication in bovine epithelial cells treated 
with rBoIFN. A plaque inhibition assay was used to quantify the capacity of individual rBoIFNs 
to inhibit replication of BHV-1 and Vesicular Stomatitis Virus (VSV). Bovine epithelial cells were 
infected with BHV-1 108 isolate 12 hours after treatment with varying concentrations of either 
recombinant bovine IFN-α (a), -β (b), or -γ (c). Data presented are the mean + 1SD of values from 
three replicate assays performed with each IFN concentration and the percent inhibition of BHV-1 
replication was calculated relative to epithelial cell cultures infected with 50 pfu of BHV-1 or VSV 
but not treated with rBoIFN. 
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3.5 Discussion 
 
IFNs provide a key innate defence against viral infections but viral pathogens have 
developed a variety of strategies to prevent either the induction of IFNs or block the 
activity of IFN-induced antiviral effector proteins. In vitro studies have identified 
numerous mechanisms by which viruses block IFN induction, IFN signaling, or disrupt the 
activity of IFN-induced anti-viral effector proteins. Few studies have been completed, 
however, to determine whether these immune evasion strategies are relevant in vivo where 
multiple IFN types or subtypes can be simultaneously activated and multiple viral 
transcripts and proteins are being expressed. BHV-1 provides an interesting example of an 
acute respiratory infection known to induce both a robust IFN-α and -γ response [67], but 
high levels of IFN secretion coincide with sustained viral replication (Fig.3.1 & 3.3). For 
the first time, we also demonstrated that a primary BHV-1 infection is associated with 
significant (P < 0.05) induction of IFN-β transcript (Fig. 3.3e) and protein (Fig. 3.3b) in the 
bovine URT.  Furthermore, induction of both type I (IFN-α and - β) and II (IFN-γ) 
responses occurred early during infection but viral replication persisted at a high level and 
for 10 days despite this multifaceted IFN response.  
Previous in vitro observations led to the conclusion that BHV-1 evaded IFN-β 
antiviral activity by inhibiting IFN-β transcription [83, 84] and inhibiting transcription of 
ISGs [85] . Our in vivo observations do not support this conclusion since IFN-β 
transcription was significantly (P < 0.05) increased in infected tissues, beginning as early 
as day 3 pi (Fig. 3.3e).  Although increased gene transcription may not result in increased 
protein production, ELISA results (Fig. 3.3b) confirmed bovine IFN-β production 
! 74!
increased significantly (P < 0.05) following BHV-1 infection. Contradictory results from in 
vitro studies [83, 84] and our in vivo study may be explained by several factors. Results 
obtained by Saira et al. [84] may be unique to the cell lines used and may not reflect the 
capacity of mucosal epithelial cells to respond to BHV-1 infection. We also designed qRT-
PCR primers to detect transcripts from the three known bovine IFN-β genes (Supplemental 
Fig. 3B) and the transcriptional response we detected may represent transcripts from 
multiple IFN-β genes. Further studies may be warranted to determine whether bICP0 is 
equally effective in inhibiting the promoter activity of all bovine IFN-β genes.  Finally, 
mucosal tissues in the URT represent a complex cell population (Fig. 3.3) with the 
potential to recruit immune cells. IFN transcript detected with RNA extracted from nasal 
turbinate and tracheal samples represents the collective response of both infected and 
uninfected cells (Fig. 3.3d-f). Other herpesvirus proteins, such as HSV-1 glycoprotein D, 
function as a potent activator of IFN responses in macrophages [218]. Thus, the IFN 
response detected at a tissue level may represent the response of a variety of cells to 
different viral proteins. The current observations highlight the importance of completing in 
vivo studies to confirm whether IFN evasion mechanisms identified in cultured cells or 
implicated by studies in an aberrant host [219] adequately explain viral immune evasion in 
the natural host.   
Other respiratory viruses, such as influenza, have been reported to induce less than 
0.15 ng IFN-α/ml in nasal secretions [220], a concentration 5 to 10-fold lower than what 
we detected following BHV-1 infection (Fig. 3.3a). Previous in vivo and in vitro 
investigations indicated that BHV-1 replication was not inhibited by either rBoIFN-α [81] 
or –γ  [82].  There was, however, no previous analysis of ISG expression in URT tissues 
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following BHV-1 infection to determine if local IFN production activated local antiviral 
defence mechanisms. The current investigation confirmed BHV-1 evades the antiviral 
activity of both type I and II bovine interferons at a concentration that effectively induced 
transcription of key antiviral effector genes (Fig. 3.6). This IFN evasion was a conserved 
trait among plaque-purified BHV-1 isolates, 108 and Cooper’s (data not shown) and in 
vitro studies support the previous conclusion that BHV-1 replication is not inhibited by 
either IFN-α or -γ (Fig. 3.7a & c). While IFN-β appeared to be a relatively weak inducer of 
antiviral effector gene transcription (Fig. 3.6b), it was the most potent inhibitor of BHV-1 
replication (Fig. 3.7b). This in vitro observation suggests IFN-β might play a role in 
inhibiting BHV-1 replication in vivo.  IFN-β may reduce the magnitude of BHV-1 
replication but the early post-infection induction of IFN-β transcription and secretion 
suggests that it may have a limited effect on the duration of virus shedding (Fig. 3.3). A 
broader analysis of ISGs induced by bovine IFN-β is necessary to determine whether 
antiviral effector mechanism(s), other than those analyzed in the present study, play a role 
in limiting BHV-1 replication.  
Previous studies of ISG expression following BHV-1 infection focused on OAS 
activity in blood leukocytes [221].  Subsequent studies confirmed that rBoIFN-α 
specifically induced OAS activity in lung macrophages and elevated OAS activity 
persisted in blood leukocytes after rBoIFN-α was no longer detectable in serum [222]. 
Current in vitro studies confirmed that rBoIFN-α is a potent inducer of OAS and other ISGs 
in bovine epithelial cells and IFN-α was at least 10-fold more effective in activating 
sustained expression of ISGs than rBoIFN–γ (Fig. 3.6). This observation is consistent with 
data reported by Liu et al. [223] and the proposal by Marié et al. [224] that IFN-α can 
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activate a positive feedback loop to amplify expression of a delayed set of IFN-α genes. 
rBoIFN-β also significantly increased the expression of OAS, Mx1 and BST-2  by 100 
to1000-fold but this induction of ISG expression was transient. 
Expression of Mx1 and OAS genes in nasal turbinates and trachea increased 
significantly (P < 0.05) within 3 days pi and elevated ISG expression persisted throughout 
the period of viral shedding. It is not possible to conclude which IFNs were responsible for 
increased ISG expression in tissues since our in vitro analyses confirmed that all three 
rBoIFNs can induce antiviral effector gene expression in bovine epithelial cells (Fig. 3.6). 
This in vitro analysis also challenges whether the ISGs analyzed in the current study 
actually play a role in restricting BHV-1 replication. However, for a closely related 
herpesvirus, HSV-1, it has been reported that Mx1 and BST-2 can restrict HSV-1 
replication [207, 225]. Both rBoIFN-α and -γ had strong antiviral activity against VSV 
replication and induced sustained ISG expression but had limited capacity to inhibit BHV-
1 replication. Based on the plaque inhibition assay results, peak IFNα and -γ levels 
detected in nasal secretions (Fig. 3.3) would have the capacity to inhibit less than 20% of 
BHV-1 replication. Thus, in vitro results support the conclusion that IFN-α and -γ have 
limited capacity to directly inhibit BHV-1 replication despite their capacity to induce 
antiviral effector genes.  In contrast, IFN-β was a more potent inhibitor of BHV-1 
replication in vitro at concentrations observed in vivo (Fig. 3.3). Thus, the early induction 
of IFN-β following BHV-1 infection may indicate that it plays an important role in limiting 
the magnitude of BHV-1 replication. 
In vitro studies confirmed that recombinant bovine rBoIFN-α and -γ induce 
sustained expression of Mx1, OAS, and BST-2 but only transient RNAse L transcription in 
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bovine epithelial cells (Fig 3.6). A significant (P < 0.01) decrease in RNAse L transcript 
was observed in nasal turbinates (Fig. 3.4d) and trachea (Fig. 3.5d) following BHV-1 
infection. These results cannot be interpreted as evidence that BHV-1 infection inhibited 
expression of this ISG if IFNs only induce transient increases in RNAse L transcript. 
Furthermore, the pattern of ISG expression observed may be tissue specific since there was 
significantly (P < 0.01) increased RNAse L transcript in trachea on day 10 pi (Fig 3.5d).  
RNAse L is potentially an important antiviral effector for limiting BHV-1 replication since 
it degrades single stranded mRNAs and inhibits translation of viral proteins [226]. 
However, while IFN-β was a potent inhibitor of BHV-1 replication in vitro, it did not 
induce increased expression of RNAse L in bovine epithelial cells (Fig 3.6b). Therefore, the 
present study provides no evidence to indicate that RNAse L may be an important antiviral 
effector protein for limiting BHV-1 replication. 
BHV-1 evasion of IFN antiviral activity, especially for IFN-α and -γ raises 
questions regarding the potential value of this multifaceted IFN response for the host.  The 
induction of this potent innate immune defence may not play a major role in limiting the 
duration of viral replication but IFN-α not only activates antiviral effector genes (Fig. 3.5) 
but also activates NK cells to produce IFN-γ [227]. IFN-γ may then have indirect antiviral 
effects through the induction of chemokines, such as CXCL10 and CXCL9, also known as 
monokines induced by IFN-γ (MIG). CXCLl0 may amplify NK-cell recruitment and MIG 
may recruit T-cells to the site of viral infection [228].  Thus, elevated IFN-γ levels at the 
site of viral infection may enhance recruitment of both innate immune cells and virus-
specific effector T-cells. NK cells were recruited to the lung following BHV-1 infection 
and these cells had an enhanced capacity to kill BHV-1 infected cells [192]. An analysis of 
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immune cells recruited to the site of BHV-1 infection in the URT may clarify whether the 
IFN response indirectly benefits the host by enhancing viral clearance through the 
recruitment and activation of immune cells.  
In conclusion, the present study confirmed that Type 1 and II rBoIFNs have the 
capacity to induce expression of several antiviral effector genes in bovine epithelial cells.  
At physiological concentrations, however, only rBoIFN-β was able to effect greater than 
50% inhibition of BHV-1 replication. In vivo studies confirmed that transcription and 
secretion of both type I and II IFNs occurs within 3 days after a primary BHV-1 infection 
and this IFN response was associated with a significantly (P < 0.05) increased expression 
of multiple antiviral effector genes in the URT.  However, viral replication in the URT 
continued for 10 days despite strong induction of both Type I and II IFN and onset of ISG 
expression early after viral infection. In vivo data supports the conclusion that BHV-1 
evasion of the IFN response does not appear to occur through an inhibition of either IFN 
gene expression or ISG transcription. 
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3.6 Supplemental Figures 
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Supplemental Figure 3A. Identification of IFN PCR products and alignment of 
BoIFN-α  and -β  gene sequences. (i) Clone manager was used to design primers targeting 
bovine interferon alpha Class 1 (BoIFN-αI1) which was identified as IFNαD through NCBI-Blast 
search. IFN PCR products were cloned and DNA-sequenced to confirm the identity and expected 
size of the PCR products. NCBI-Blast search confirmed that the cloned IFNαD product (ii) was 
IFNαD (XM_005209896.1) with 99% homology. (iii) Cloned IFNβ product A was identified as 
IFNβ2 (XM_603903.7) with 99% homology and (iv) cloned IFNβ product B was identified as 
IFNβ1 (NM_174350.1) with 96% homology. 
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B. (i) 
1 CAAGAGGGAA CTTTCAGAAA ATGGAAACCA TGGACTCCTA TTTAAGACAC 
AGACCTGAAG         
 
    GATGACAGCAGAAATGAGTCTTCC!  
61 GAAGGTCTTC AGAGAACCTA GAAAGCAGGT TCACAGAGTC ACCCACCGCC 
CCAGGCCACA        
 
121 AGCATCTTCA AGGTCCCCGA TGGCCCCAGC CTGGTCCCTC CTCCTGGCTC 
TGCTGCTGCT        
      <-ACACACACCTGGTTCAACAC 
 
181 CAGCTGCAAC GCCATCTGCT CTCTGGGCTG CCACCTGCCT CACTCCCACA 
GCCTGGCCAA        
 
241 GAGGAGAGTC CTGACACTCC TGCGACAACT GAGGAGGGTC TCCCCTTCCT 
CCTGCCTGCA        
 
301 GGACAGAAAT GACTTCGCAT TCCCCCAGGA GGCGCTGGGT GGCAGCCAGT 
TGCAGAAGGC        
 
361 TCAAGCCATC TCTGTACTCC ACGAGGTGAC CCAACACACC TTCCAGCTTT 
TCAGCACAGA        
 
421 GGGCTCGGCC GCTGTGTGGG ATGAGAGCCT CCTGGACAAG CTCCGCACTG 
CACTGGATCA        
 
481 GCAGCTCACT GACCTGCAAG CCTGTCTGAG GCAGGAGGAG GGGCTGCCAG 
GGGCTCCCCT        
 
541 GCTCAAGGAG GACTCCAGCC TGGCTGTGAG GAAATACTTC CACAGACTCA 
CTCTCTATCT        
 
601 GCAAGAGAAG AGACACAGCC CTTGTGCCTG GGAGGTTGTC AGAGCACAAG 
TCATGAGAGC        
 
661 CTTCTCTTCC TCAACAAACT TGCAGGAGAG ATTCAGGAGA AAGGACTGAC 
ACACACCTGG        
 
721 TTCAACACGG AAATGATTCT CACGGACCAA CAGACCACAC TTCCTCCTGC 
GCTGCCATGT        
 
781 GGAAGACTCA TTTCTGCTGT CATCAGGCAC TGAACTGAAT CAATT  
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Supplemental Figure 3B. Alignment of the forward and reverse primers specific to 
boIFN type I genes. Clone manager was used to design primers targeting bovine interferon alpha 
Class 1 (boIFN-αI1) which was identified as IFNαD through NCBI-Blast Search. (i) Alignment of 
IFNαD (XM_005199122) primer binding sites with IFNαD sequence. IFNβ primers were designed 
with IUPAC nucleotides to target all three types of boIFNβ, boIFNβ1 (NM_174350), boIFNβ2 
(NM_001015617.1) and boIFNβ3 (NM_001114297.1) 
 (ii) Alignment of boIFNβ primers with boIFNβ1, boIFNβ2, and boIFNβ3 sequences.  
 
 
 
 
 
 
 
 !!!!!!!!!!!!!!!!!!!!!!!!!!
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Linking Statement !!!
Data in the previous chapter provided evidence that the induction of interferon and 
interferon-induced antiviral effector genes occurred early during a primary BHV-1 
infection but this multifaceted antiviral response was not sufficient to control a primary 
BHV-1 respiratory infection by reducing viral shedding and clinical disease. BHV-1 
evasion of type I and II IFN induced antiviral activity in vitro and in vivo raised questions 
regarding the value of this IFN response for the host. IFN-γ may have indirect antiviral 
effects through the induction of chemokines, such as CXCL9 and CXCL10. CXCLl0 may 
amplify NK-cell recruitment and CXCL9 may recruit T-cells to the site of viral infection 
[228].  Thus, elevated IFN-γ levels at the site of viral infection may enhance recruitment of 
either innate immune cells or virus-specific adaptive effector T-cells. Non-MHC restricted 
cells were reported to be recruited to the lung following BHV-1 infection and these cells 
had an enhanced capacity to kill BHV-1 infected cells [192]. The phenotype and frequency 
of immune cells present in URT tissues following primary BHV-1 infection were then 
analyzed to determine whether specific innate or adaptive effector cells may be recruited 
early during infection. IFN responses may indirectly benefit the host by enhancing viral 
clearance through either the recruitment or activation of immune effector cells at the site of 
infection. Alternatively, if IFN production does not precede cell recruitment, then 
increased IFN-γ production at the site of viral infection may simply be a by-product of 
having an increased number of activated innate or adaptive effector cells to the site of 
infection. In the next chapter, I investigated lymphocyte recruitment to the URT following 
a primary BHV-1 respiratory infection.!
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CHAPTER 4: CD335 (NKP46)+ T-CELL RECRUITMENT TO THE BOVINE UPPER 
RESPIRATORY TRACT DURING A PRIMARY BOVINE HERPESVIRUS-1 
INFECTION   !
This chapter has been published in Frontiers in Immunology as: 
Osman RA, Griebel PJ. CD335 (NKp46)+ T-Cell Recruitment to the Bovine Upper 
Respiratory Tract during a Primary Bovine Herpesvirus-1 Infection. Front Immunol. 2017 
Oct 23;8:1393. doi: 10.3389/fimmu.2017.01393. eCollection 2017. PubMed PMID: 
29114252; PubMed Central PMCID: PMC5660870. 
I was co-responsible for conception, design of the study and writing the manuscript. I 
designed and validated primers, performed experiments, and analyzed the data.  !
Relevance of this study to the Thesis 
This study addressed questions presented within the second hypothesis of this thesis. 
Lymphocyte recruitment to the upper respiratory tract during a primary BHV-1 infection 
was analyzed and CD335+ non-conventional T-cells were identified as the major 
lymphocyte subpopulation recruited during viral infection.  !
4.1. Abstract 
 
Bovine Natural Killer (NK) cells were originally defined by the NK activation receptor, 
CD335 (NKp46) but following the discovery of NKp46 expression on human T-cells, the 
definition of conventional bovine NK cells was modified to CD335+CD3- cells. Recently, a 
bovine T cell population co-expressing CD335 was also identified and these non-
conventional T-cells were shown to produce IFN-γ and share functional properties with 
both conventional NK cells and T-cells. It is not known, however, if CD335+ bovine T 
cells are recruited to mucosal surfaces and what chemokines may play a role in recruiting 
this unique T cell subpopulation. In this study, bovine herpesvirus -1 (BHV-1), which is 
closely related to herpes simplex virus-1, was used to investigate bovine lymphocyte cell 
populations recruited to the upper respiratory tract (URT) following a primary respiratory 
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infection in calves. Immunohistochemical staining with individual monoclonal antibodies 
revealed significant (P < 0.05) recruitment of CD335+, CD3+ and CD8+ lymphocyte 
populations to the nasal turbinates on day 5 following primary BHV-1 infection. Analysis 
by dual-colour immunofluorescence revealed that the cells recruited to nasal turbinates 
were primarily T cells that co-expressed both CD335 and CD8α. This non-conventional T 
cell population represented 77.5% to 89.5% of the lymphocytes recruited to nasal 
turbinates on day 5 post-BHV-1 infection. However, due to diffuse IFN-γ staining of nasal 
turbinate tissue, it was not possible to directly link increased IFN-γ production following 
BHV-1 infection with the recruitment of non-conventional T-cells. Transcriptional analysis 
revealed CCL4, CCL5 and CXCL9 chemokine gene expression was significantly (P < 
0.05) up-regulated in nasal turbinate tissue following BHV-1 infection. Therefore, no 
single chemokine was associated with recruitment of non-conventional T-cells.  In 
conclusion, the specific recruitment of CD335+ and CD8+ non-conventional T cells to viral 
infected tissue suggests these cells may play an important role in either the clearance of a 
primary BHV-1 infection or regulating host responses during viral infection. The early 
recruitment of non-conventional T-cells following a primary viral infection may enable the 
host to recognize viral-infected cells through NKp46 while retaining the possibility of 
establishing T cell immune memory.!
 
4.2. Introduction 
 
Bovine herpes virus-1 (BHV-1), a member of Alphaherpesvirinae subfamily, is an 
important pathogen contributing to bovine respiratory disease (BRD) complex in young 
calves. BHV-1 causes a rhinotracheitis in the upper respiratory tract (URT) [71] and, 
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similar to other alphaherpesviruses in humans, pigs and horses, causes a lytic infection of 
mucosal epithelial cells [229] followed by a latent infection in the peripheral nervous 
system. The primary sites of BHV-1 infection in the URT include the nasal turbinates, 
pharyngeal tonsils and trachea [61]. Previous studies suggested that IFNs does not play a 
major role in the clearance of a primary BHV-1 infection [230] but cytotoxic cell-mediated 
immune responses mediated by macrophages, neutrophils, natural killer (NK) cells, and 
cytotoxic T-lymphocytes (CTLs) may contribute to viral clearance [192, 231, 232].  
 
NK cells are non-antigen specific innate lymphocytes that respond rapidly to both 
infectious and non-infectious challenges. NK cells express both activation and inhibitory 
receptors. These heterologous receptors include killer-cell immunoglobulin-like receptors 
(KIR) and natural cytotoxicity receptors (NCR) such as NKp46 (NCR1 or CD335), NKp30 
and NKp44 [233]. CD335 is the only NK receptor currently characterized for bovine NK 
cells [155] and is an activating receptor on NK cells which binds ligands and initiates 
signalling that activates cytotoxic responses. This process was demonstrated by activation 
of human NK cell cytotoxicity following NKp46 -binding of hemaglutinin (HA) of 
influenza viruses [234]. This activation signal results in the release of cytotoxic granules, 
which kill target cells through the combined action of perforin and granzyme [235].  
 
CD335 was originally described as a bovine NK cell specific receptor [155] but a small 
subpopulation of bovine T-cells have also been identified that co-express CD335+ [155, 
157, 159, 160]. CD335+CD3- cells are now defined as classical or conventional NK cells 
and lymphocytes that co-express CD3 with CD335+ are described as non-conventional T 
! 90!
cells. Multiple non-conventional T-cells have been reported in several mammalian species, 
including humans[161], mice [236], pigs [159] and bovine [157]. The discovery of 
reprogrammed human cytotoxic T-lymphocytes, which co-express CD3 and NKp46 in 
celiac disease [161] highlighted the existence of T-cells acquiring natural cytotoxicity 
receptors (NCRs) previously associated with NK cells. Other non-conventional T-cells 
include Natural killer T-cells (NKT) and mucosal associated invariant T-cells (MAIT) that 
co-express CD3 and NCRs.   
 
 NKT cells were first discovered in mice [237]  and characterized as a T cell subpopulation 
expressing NK1.1, and αβT-cell receptors [237, 238]. In other species that do not express 
NK1.1, the term NKT has been used to refer to T-cells which co-express NK cell receptors 
[239]. NKT cells studied in humans and mice were shown to express an invariant TCR and 
were termed invariant (i)NKT cells. This population recognized a limited repertoire of 
ligands relative to the extensive repertoire of conventional MHC-restricted T-cells. NKT 
cells also recognize lipid ligands complexed with the non-MHC surface molecule, CD1d, 
and were referred to as “CD1d-restricted” T-cells [162]. CD1d is absent in cattle [91] but 
bovine T cells co-expressing CD335 do recognize lipid ligands by a CD1d-independent 
mechanism [92].  
 
MAIT cells were first reported in human blood by Porcelli et al [240] as unconventional 
αβT-cells with invariant TCRα chain and semi-invariant TCR repertoire.  These non-
conventional T-cells have since been identified in mice and found to be enriched at 
mucosal surfaces [163]. MAIT cells recognize antigens in the context of a non-classical-
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MHC molecule, MR1 [163]. Recent studies have shown that MAIT cells have 
antimicrobial functions [241] and recognize vitamin B metabolite ligands [242]. MAIT 
cells have not been characterized in cattle but bovine non-conventional T-cells that co-
express CD335 have been shown to have a cytotoxic effector function with parasite 
infected cells and secrete IFN-γ [157]. No information is available, however, regarding the 
role of these cells in controlling infections at mucosal surfaces.  
 
Homing of innate and adaptive lymphocytes to sites of viral infection is crucial for 
effective cell-mediated immune responses and clearance of viral infected cells. Different 
non-conventional T-cell subsets home to specific tissues based on their expression of 
chemokine receptors and intrinsic tissue responses to pathogens or other danger 
signals[243]. Murine iNKT cells express CCR7, CXCR3, CXCR6, CCR4 and CCR6 
chemokine receptors [194], of which CCR4 [195] is important for pulmonary localization. 
CXCR6, CCR1, and CCR6 are expressed by human NKT cells [196] but the chemokine 
receptors expressed by  bovine non-conventional T-cells and the chemokines involved in 
their recruitment to specific tissues has yet to be determined. Previous studies 
demonstrated that non-MHC restricted lymphocytes were recruited to the lungs of calves 
following BHV-1 infection [192] but it was not determined whether these cells were 
conventional NK cells or non-conventional T cells. It is not known if  non-conventional T-
cells may be recruited to bovine mucosal surfaces since previous studies of bovine non-
conventional T cells were limited to cells isolated from blood [91, 92, 157].  
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In this study we demonstrate that non-conventional T-cells co-expressing CD335 and CD8 
are recruited to the bovine URT following an experimental BHV-1 infection and these non-
conventional T-cells are the major effector cell population recruited within 5 days post-
infection (pi). Our analysis of chemokine gene expression at the site of viral infection also 
identified multiple chemokines that may be involved in the highly specific recruitment of 
this non-conventional T-cell population. Thus, CD335+ and CD8+ bovine non-conventional 
T- cells appear to be the primary effector cell populations involved in the early immune 
response to a BHV-1 URT infection. 
 
4.3. Materials and Methods 
 
4.3.1.  Animals: 
 
Female and castrated male, 5 to 6 month old, crossbred (Angus X Hereford) calves (n=30) 
were purchased from a single commercial herd. Calves were identified as seronegative for 
BHV-1 by screening with a recombinant, truncated glycoprotein D (tgD) antibody capture 
ELISA [208]. Calves were weaned, transported to the research facility, and adapted for 2 
weeks to a diet of free choice hay and 0.5 kg oats/day. During the adaptation period calves 
were housed as a single group and there was no contact with other cattle. The average 
weight of calves was 232 kg (range = 174 and 242 kg) and animals were housed in a single 
pen throughout the study. All experimental procedures were conducted according to the 
Guide to the Care and Use of Experimental Animals, provided by the Canadian Council on 
Animal Care and the experimental protocols were approved by the University of 
Saskatchewan Animal Care Committee (Protocol #19940211 and 19940218). The animals 
used for tissue collection were the same animals used to analyze virus shedding, IFN gene 
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expression, and the expression of IFN-stimulated genes in a previous study [230]. In our 
previous study, we demonstrated that all infected animals shed greater than 105 infectious 
virus particles/ml of nasal secretion at the time tissues were collected between days 3 to 7 
post-infection [230]. BHV-1 infection of nasal turbinate mucosal epithelium was also 
confirmed by immunohistochemical staining [230]. 
 
4.3.2.  Experimental Infection and Sample Collection: 
 
Six (6) of the 30 calves served as uninfected controls and tissue samples were collected 
from the control animals immediately prior to challenging the remaining 24 calves with 
BHV-1. This ensured there was no potential exposure of control calves to BHV-1. The 24 
infected calves were aerosol challenged with BHV-1 isolate 108 (5 X 107pfu/animal) on 
Experimental Day 0 as previously described [67]. A clinical veterinarian, blinded to 
treatment group, examined calves daily and recorded body weight and temperature. For 
tissue collection, cohorts of 6 calves were randomly selected and euthanized with an 
intravenous injection of Euthanyl (240 mg/ml; Bimeda-MTC, Canada) on Days 3, 5 7, and 
10 pi. Tissue samples were collected within 15-20 minutes after euthanasia and three 
replicate samples were immediately placed in RNAlater or 10% buffered formalin. Tissue 
samples from nasal turbinates were collected 10-12 cm from the external nares of all calves 
(Supplemental Figure 4A). A 4-5mm2 piece of nasal turbinate was placed on the surface of 
a 4-5 mm2 and 1 mm thick slice of fresh liver tissue with the epithelial surface of the 
turbinate supported by the liver. This protected the mucosal epithelium from damage 
during cryosectioning. Tissue blocks were snap-frozen in liquid nitrogen and stored at-
80oC until tissues were used for cryosectioning and immunohistochemical (IHC) staining. 
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Formalin-fixed tissues were used for histology and IHC detection of BHV-1 proteins. 
Tissues fixed with RNAlater were stored at -80oC until RNA was extracted for qRT-PCR 
analysis of bovine chemokine gene expression.  
 
4.3.3.  Monoclonal Antibodies 
 
The monoclonal antibodies (mAbs) used for IHC and immunofluorescence (IF) and 
relevant isotype controls are listed in Table 1, which provides details on mAb specificity 
and the concentration of each mAb used for staining. 
 
Table 4.1. Monoclonal Antibodies Used For Immunohistochemistry and 
Immunofluorescence  
    
           a Cluster of differentiation;  
b T-cell Receptor;  
c T-helper cells;  
d Dendritic cells; 
 e Cytotoxic T-lymphocytes; 
f Natural cytotoxicity triggering receptor 1;  
g Natural Killer cell p46-related protein. 
 
CD a 
Target 
molecule 
Target 
population 
 
Isotype 
 
mAb Clone 
 
Conc. 
 
Source 
CD3 TCRb 
complex 
Pan-T-cells IgG1 MM1A 667ng/ml VMRD 
CD4 CD4 TH cells c, DCd IgG1 CACT138A 10µg/ml VMRD 
CD8 CD8α CTLs e, DC IgG1 CACT80C 5µg/ml VMRD 
CD335 NCR1f, 
NKp46 g 
Innate 
lymphoid cells 
IgG1 AKS1 10µg/ml Bio-Rad 
sIgA Surface 
IgA 
IgA  
plasma cells 
IgG1 BIG312D3 125ng/ml VMRD 
IFN-α  IFN-α IFN-α IgG1 Ascites 1:400 
dilution 
VIDO 
IFN-γ  IFN-γ IFN-γ IgG1 7B6 2µg/ml LSBio 
Isotype 
Control 
  IgG1 MG100 5µg/ml Life 
Tech. 
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4.3.4.  Lymphocyte Phenotyping with Immunohistochemistry  
 
We collected three 4-5mm2 nasal turbinate tissue samples from each animal and the tissue 
block selected for cryosectioning was chosen randomly to avoid bias. The nasal turbinate 
tissue block was sectioned at-20oC and serial 5µm sections were cut using a cryostat 
(DAMON/IEC Division, Microtome 3398) and mounted on Superfrost Plus slides 
(Fisherbrand#12550215, Ontario, Canada). The tissue sections selected for IHC staining 
were chosen on the basis of optimum tissue morphology. Tissue sections were fixed in 
chilled 100% acetone for 8 minutes and air-dried for 20 minutes prior to storage at 4oC. An 
IgG1 isotype control was included at the same concentration as the primary antibody to 
control for non-specific binding of primary and secondary antibodies, and confirmed that 
non-specific staining due to endogenous expression of hydrogen peroxidase, avidin and 
biotin was adequately blocked. Indirect-immunolabelling was performed as described 
previously [244] to visualize the location and distribution of IFN-α and IFN-γ in tissue 
sections and to perform morphometric analyses of the frequency of CD335+, CD3+, CD8+ 
and CD4+ cells in nasal turbinates before infection (Day 0) and on Day 3, 5, 7 and 10 post-
BHV-1 infection. Biotin-conjugated goat-anti-mouse IgG (Vector Laboratories, 
Burlingame, CA, USA #BA-9200) and the Vectastain Elite Avidin-Biotin complex (ABC) 
Kit (Vector Laboratories, Burlingame, CA, USA #PK4000) were used to visualize bound 
mAbs.  BHV-1 infection occurs primarily within mucosal epithelial cells of the nasal 
turbinate [230]. Thus boundaries set for morphometric analysis of individual lymphocyte 
populations included the mucosal epithelium and the underlying lamina propria region. 
Five contiguous microscopic fields (total area = 0.196 mm2) were analyzed within each 
tissue section and cells with visible staining were manually counted using an Olympus 
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CX31 microscope (Olympus, Center Valley, PA, USA) with a 40X objective. The first 
field counted was located at the upper left corner of the cryosection and four contiguous 
fields were then counted. The top margin of each field was defined by the external surface 
of the mucosal epithelium and included the underlying lamina propria.  An Olympus BX51 
microscope & DP70 digital camera system (Olympus, Center Valley, PA, USA) were used 
to capture images of IHC stained cryosections.  
 
4.3.5.  Immunofluorescence 
 
Dual-colour staining of tissue sections was performed using fluorochrome-conjugated 
mAbs that reacted with bovine CD3, CD8 and CD335. The mAbs (Table 1) were 
conjugated with fluorochromes using Molecular Probes® Antibody Labeling Kit 
(Thermofisher Scientific, Carlsbad, CA, USA), following the manufacturer’s instructions. 
The anti-bovine CD3 mAb was conjugated with Alexa Fluor® 594.  The anti-bovine CD8 
mAb was conjugated with Alexa Fluor® 488 and Alexa Fluor® 594 so it could be used in 
appropriate combinations with the fluorochrome conjugated CD3 and CD335 mAbs. The 
anti-CD335 mAb was conjugated with Alexa Fluor® 488.  IgG1 isotype control mAb 
(Table 4.1) was conjugated with Alexa Fluor® 594 to be used for confirmation of staining 
specificity of the three other fluorochrome-conjugated antibodies. Direct fluorochrome 
labeling was necessary since the three mAbs are all IgG1 isotype (Table 4.1) and mAb 
reactivity after fluorochrome conjugation was confirmed by flow cytometric analysis of 
labelled blood mononuclear cells. Serial nasal turbinate cryosections were cut and fixed as 
described previously and stored at 4 oC overnight. Acetone-fixed sections were brought to 
room temperature, air-dried for 30 minutes, and then rehydrated with phosphate buffered 
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saline (PBS). The PBS solution was changed three times at 5 min intervals before slides 
were blocked by incubating with 10% normal goal serum for 3 hours, followed by a 5 
minute wash with PBS.  Tissue sections were then flooded with 200 µl of PBS containing 
5% normal goat serum and one of the following combinations of fluorochrome-conjugated 
mAbs:  CD3 and CD335; CD335 and CD8; or CD3 and CD8.  Cryosections were 
incubated in the dark at room temperature for 2.5 hours before washing twice for 5 minutes 
with PBS that was mixed with a magnetic stirrer.  Tissue sections were counterstained by 
flooding with 200µl 4′, 6-diamidino-2-phenylindole (DAPI; 1µg/ml methanol) (Life 
Technologies, Camarillo, CA, USA) for 10 minutes at room temperature to visualize cell 
nuclei and then washed for 5 min with PBS. Tissue sections were cover slipped with 
Cytoseal 60 mounting media (Thermofisher Scientific, Carlsbad, CA, USA) and stored 
overnight at 4 oC before fluorescent imaging was completed. Confocal images were 
generated using a Leica TCS SP8 scanning confocal microscope (Leica Microsystems, 
Wetzlar, Germany), equipped with a 63X oil immersion objective and utilizing the 405 nm 
(UV) and 561 nm laser lines. Confocal images from a minimum of 15 microscopic fields 
were captured per sample and a minimum of 100 CD335+, CD3+ and CD8+cells were 
counted per tissue section. Tissue sections were analyzed for nasal turbinate samples 
collected from three animals on day 5 pi to determine the frequency of CD335+CD3+, 
CD335+CD8+ and CD3+CD8+ cells.  
 
4.3.6.  RNA Extraction  
 
RNAlater® fixed nasal turbinate samples were homogenized as previously described [8] 
and total RNA was extracted using the RNeasy mini Kit (Qiagen Inc. Ontario, CA) 
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following the manufacturer’s protocol.   RNA quality and total RNA were determined 
using the Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA). 
Samples with an RNA Integrity Number (RIN) of 8 or higher were used to prepare cDNA. 
 
4.3.7.  cDNA synthesis 
 
Total RNA (1µg) was reverse-transcribed using qScript™ cDNA SuperMix (Quanta 
Biosciences™ Beverly, MA, USA), following the manufacturer’s protocol. cDNA samples 
were diluted in DNAse/RNAse free water for use as template in qRT-PCR reactions.  
 
4.3.8.  qRT-PCR primer design and validation 
 
Primer pairs for chemokine transcripts (Table 4.2) were designed using Clone Manager 9.0 
program (Sci-Ed Software). Primer specificity for individual chemokine genes was 
confirmed through generation of a single peak in the melting curve and detecting a single 
amplicon following gel electrophoresis of PCR products. PCR products were also cloned in 
the PCR 2.1 vector using the TA cloning kit (Life Technologies, Camarillo, CA, USA). 
Cloned products were sequenced with a CEQ 200XL DNA Analysis system (Beckman 
Coulter) to confirm product identity and size. Primer amplification efficiency (Table 4.2) 
was determined using standard curves as described previously [213].  
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Table 4.2 Primers For Amplification Of Bovine Chemokine Genes And Reference Genes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* Sequence of forward (FWD) and reverse (RV) primers; 
§ Size of amplified PCR product; 
‡ Efficiency of product amplification
 
Gene 
  
Primer Sequence* 
 
Size 
§ 
 
Effic.‡ 
CCL2  
(MCP-1) 
FWD TCGCTGCAACATGAAGGTCT 119 2.02 
 RV TATAGCAGCAGGCGACTTGG   
 
CCL3  
(MIP-1α) 
 
FWD 
 
CGGCAGCTTTCTCGCAAAAT 
 
166 
 
1.98 
 RV CCTCTCAGGCATTCAGCTCC 
 
  
CCL4 
 (MIP-1β) 
FWD AGCTCTGCGTGACTGTCCTG 86 2.15 
 RV AGGGTCTGAGCCCATTGGTG 
 
  
CCL5 
(RANTES) 
FWD GCTCCATGGCAGCAGTTGTC 128 2.12 
 RV AGGTTCAAGGCGTCCTCCAC 
 
  
CCL19  
(MIP-3β) 
FWD AGGTGCCAACGACGCTGAAG 92 2.17 
 RV TGAGGAGCAGGTAGCGGTAG 
 
  
CCL20 (MIP-3α) FWD GACTGCTGTCTCCGATATAC 90 1.98 
 RV GATGTCACAGGCTTCATTGG 
 
  
CCL21 FWD TGGTCCTGAGCATCCTTGTC 
 
114 2.07 
 RV TGGCGGGAATCTTCTTTCGG 
 
  
CXCL8  
(IL-8) 
FWD CGCTGGACAGCAGAGCTCACA 106 2.06 
 RV TGCCAAGAGAGCAACAGCCAGC 
 
  
CXCL9 (MIG) FWD AGTGGGAGAAACAGGTCAAC 129 2.13 
 RV AAGTGGGAGCTCATGTAGTC 
 
  
CXCL10 (IP-10) FWD AAGGGAAAGGGTGGCTCATC 114 1.98 
 
 
RV GGCTGGGACTTAGCACATTG   
CXCL-11 (IP-9) FWD AGCAGCAACAAGCATGAGTG 100 2.10 
 RV CCGTCCGCCTTTGAACATAG 
 
  
β-Actin FWD CTAGGCACCAGGGCGTAATG 
 
116 2.00 
 RV CCACACGGAGCTCGTTGG 
 
  
GAPDH FWD                  TGGAAAGGCCATCACCATCT 
 
0 2.7 
 RV CCCACTTGATGTTGGCAG 
 
  
RPS9 FWD CCTCGACCAAGAGCTGAAG 
 
2 2.7 
 RV CCTCCAGACCTCACGTTTGTTC 
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4.3.9.  qRT-PCR Analysis of Chemokine Gene Expression 
 
Gene expression data for individual samples was normalized relative to β-actin, which 
was confirmed to be stable over multiple time points and not affected by BHV-1 
infection in nasal turbinates (data not shown). We also analyzed the expression of 
GAPDH and RPS9 reference genes. The expression of the three reference genes did not 
differ significantly when comparing samples collected at different time points following 
BHV-1 infection (data not shown), but β-actin transcription displayed the least variability 
among animals at each time point. The β-actin gene also had the lowest Cq value when 
comparing among the three reference genes and was therefore selected as the best 
reference gene for detection of genes with high transcriptional levels. qRT-PCR was 
performed using the PerfeCTa® SYBR® Green FastMix for iQ (Quanta BioScience, 
Beverly, MA, USA). Briefly, 9 µl of Perfecta SYBR green master mix (2X), 3 µL of the 
primer pair at 3.3 µM, and 3 µL cDNA template were added to a 15 µL final volume. 
The reaction was performed in BioRad iCycler iQ PCR detection system using the 
following program: 1 cycle at 95 °C for 30 sec, 45 cycles of 95 °C for 15 sec, 60 °C for 
30 sec and 72 °C for 30 sec. After cycling, the temperature was increased starting from 
56 °C at a rate of 1 °C every 10 sec to build a melting curve (40 times). Amplification 
data obtained for individual genes was expressed as quantification cycle (Cq) and was 
subtracted from the Cq of the β-actin reference gene to obtain ΔCq (ΔCq = Cq gene – Cq 
β-actin).   
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4.3.10.  Statistical Analysis: 
 
All statistical analyses in were performed using GraphPad software (Version 7.0a, La 
Jolla, CA, USA). A one-way ANOVA with Holm-Sidak’s multiple comparisons test was 
used to compare the frequency of leukocyte subpopulations in nasal turbinates before 
BHV-1 infection (Day 0) with each day sampled pi. A Mann-Whitney test was used to 
analyze changes in the expression level of individual chemokine genes in nasal turbinates 
a following BHV-1 infection relative to pre-infection (Day 0) levels.  
 
4.4. Results 
 
4.4.1.  Interferon production in nasal turbinate tissue 
 
Previous studies confirmed IFN-α and -γ gene expression in nasal turbinates and 
the concentration of IFN in nasal secretions increased following a primary BHV-1 
infection [67, 230]. IHC staining of nasal turbinate cryosections with mAbs specific for 
bovine IFN-α and -γ was performed to determine if the production of these cytokines 
could be localized to specific cells within the tissue. IHC staining revealed, however, a 
diffuse staining pattern with the most intense staining associated primarily with mucosal 
epithelial cells (Figure 4.1c & 4.1d).  Diffuse staining was occasionally observed 
throughout the lamina propria but there was no consistent pattern and staining could not 
be localized to individual cells. Isotype-matched mAbs were used to confirm the 
specificity of the staining observed at the mucosal surface and in the lamina propria (data 
not shown). Due to the diffuse and inconsistent staining pattern observed for IFN in 
tissue sections, a qualitative analysis was used to determine the frequency of positive 
staining in nasal turbinates collected from animals before and after BHV-1 infection. 
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Some of the nasal turbinate samples collected from uninfected animals were positive for 
IFN-α (3/6 animals; 50%) and IFN-γ (4/6 animals; 60%) (Figure 4.1a & 4.1b).  IHC 
staining of Day 5 tissue sections revealed more intense IFN-α staining of the epithelial 
cell layer in all animals but only 80% (5/6 animals) of the tissue samples were positively 
stained for IFN-γ. The staining reaction was darkest at the epithelial surface and 
generally less intense in the lamina propria (Figure 4.1c & 4.1d).  Positive staining for 
Type I IFN on Day 0 may reflect environmental exposure to other pathogens or 
commensal microbes that maintain a basal level of innate immune activation in mucosal 
epithelium of the upper respiratory tract. IFN-α is a potent activator of NK cells, which 
may explain the concurrent expression of IFN-γ if these innate immune cells are present 
in the tissue. Therefore, we investigated the types of lymphocytes present in nasal 
turbinates before and after BHV-1 infection.  
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Figure 4.1. Type 1 and 2 interferon secretion in nasal turbinates following a 
primary respiratory BHV-1 infection of naïve calves. IHC staining of cryopreserved 
nasal turbinate tissues with mouse anti-bovine IFN-α and anti-bovine IFN-γ monoclonal 
antibodies was used to visualize the location of IFN-α  (a & c) and IFN-γ (b & d) protein. 
Representative tissue sections are presented to demonstrate an absence of staining in the 
uninfected control (Day 0) and the pattern of staining 5 days (Day 5) after BHV-1 infection. 
Diffuse staining of nasal turbinate epithelial surfaces (arrows) was observed in both uninfected 
and BHV-1 infected calves and the percent animals (n = 6/time point) with positive IFN-α (e) 
and IFN-γ (f) staining in nasal turbinates is shown. One tissue section was stained per animal. 
Brown color shows positive staining. 
 
4.4.2.  Lymphocytes present in nasal turbinates following BHV-1 infection 
 
We previously demonstrated that bovine IFN-γ had limited direct antiviral 
activity, despite high levels of IFN-γ production during a primary BHV-1 infection[230]. 
Thus, the role IFN-γ may play in clearing a primary BHV-1 respiratory infection is not 
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known. One hypothesis is that increased IFN-γ production may reflect increased 
recruitment of either NK cells or T-cells to the site of viral infection and subsequent 
activation of these cells by Type I IFNs. Nasal turbinates are a site of BHV-1 infection 
and replication and therefore, to test this hypothesis nasal turbinate tissue was collected 
from BHV-1 infected calves. IHC was used to analyze the phenotype and frequency of 
innate and adaptive lymphocytes present in the tissue.  
 
Lymphoid populations present in nasal turbinates were first analyzed by staining 
for T cells (CD3) and both conventional NK cells and non-conventional T-cells, which 
express CD335. Tissue sections were also stained for CD4 and CD8α which are markers 
for subsets of α/βTcR T cells [11], and are also expressed on bovine NK cells and non-
conventional T-cells [157]. Morphometric analysis of tissue sections revealed that both T 
cells (CD3+) and either conventional NK cells or non-conventional T-cells (CD335+) 
were present at low levels in nasal turbinates prior to BHV-1 infection (Figure 4.2).  
Cells staining for CD4 and CD8 were also present at low levels in the lamina propria 
prior to viral infection (Figure 4.2b & c; Figure 4.3c; CD4 staining not shown).  The 
number of CD335+, CD8+, and CD3+ cells present in the epithelial and lamina propria 
compartments increased significantly (P < 0.05) on Day 5 pi (Figure 4.2c and Figure 4.3) 
when compared to the number of cells present prior to infection (Figure 4.2). The 
increased number of cells present in nasal turbinates on Day 5 then declined to pre-
infection levels on days 7 and 10 pi.  In contrast, there was a significant (P < 0.05) 
decrease in the number of CD4+ cells on days 3, 7, and 10 pi (Figure 4.2).  Cells staining 
for CD3 were the most abundant on Day 5 pi, exceeding 100 cells per field (0.196 mm2) 
105!!
examined.  The high frequency of CD3 cells on Day 5 pi could not be accounted for by 
adding the total number of CD4+ and CD8+ cells, suggesting that other CD3 co-
expressing cell populations may be recruited to the nasal turbinates following viral 
infection.  γδTCR T cells are a major T cell subpopulation present at mucosal surfaces of 
ruminants [245] but the mAbs evaluated for bovine γδTCR staining reacted strongly with 
the mucosal epithelium. This non-specific staining precluded an accurate enumeration of 
all known T cell subpopulations present in nasal turbinates following BHV-1 infection. 
IHC staining for IgA plasma cells also revealed consistently low numbers both before 
and after BHV-1 infection (data not shown).  
 
Figure 4.2. Frequency of lymphoid subpopulations present in nasal turbinates 
following a primary BHV-1 infection. Immunohistochemical staining was performed with 
monoclonal antibodies to identify CD335 (a) CD8 (b) CD4 (c), and CD3 positive cells (d). 
Morphometric analyses were used to quantify the frequency of each cell type located within the 
nasal turbinate epithelial and submucosal compartments. Data presented are the mean and 
standard error of the mean for values from tissues sections analyzed from 6 animals/time point 
following BHV-1 infection. One-way ANOVA was used to compare values relative to pre-
infection (Day 0) levels and significant changes in frequency of leukocytes relative to Day 0 are 
indicated as  P < 0.05 (*), P ≤ 0.01 (**), P ≤ 0.001 (***),   P ≤ 0.0001 (****). 
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4.4.3.  Non-conventional T-cells are recruited to nasal turbinates following BHV-1 
infection  
 
The CD335 mAb binds to the NKp46 receptor on innate immune cells and is 
involved in the activation of NK cells and target cell lysis [155]. The NKp46 receptor is, 
however, expressed on a variety of lymphocytes, which includes both conventional NK 
cells (CD335+CD3-) and non-conventional T-cells (CD335+CD3+) that play key roles in 
host immune defences and inflammation [157].  Therefore, we further investigated the 
phenotype of the CD335 cells recruited to nasal turbinates during BHV-1 infection to 
determine if this might account for the large increase in CD3+ cells. A double staining 
protocol was optimized to determine if CD335+ cells co-expressed CD8 (Figure 4.4a-c) 
or CD3 (Figure 4.4d-f).  On average, 77.5% of CD335+ cells present in nasal turbinates 
on day 5 pi co-expressed CD3 while 22.5% of the CD335+ cells expressed markers 
typical for conventional NK cells (CD335+CD3-) (Figure 4.4g). Further, 89.7% of 
CD335+ cells present on day 5 pi co-expressed CD8 (Figure 4.4g).  Conversely, 78.5% of 
CD3+ cells present in the nasal turbinates on day 5 pi co-expressed CD335 while 21.8% 
of the CD3+ cells co-expressed the markers of conventional T-cells (CD3+CD335-) 
(Figure 4.4i). Furthermore, co-staining for CD8 and CD3 revealed 86.6% of CD8+cells 
recruited to the nasal turbinates on day 5 pi co-expressed CD3 (data not shown). Double 
staining for CD8 and CD3 also indicated that only 73.4% of CD3 cells co-expressed 
CD8, which verified that other CD3-expressing cell populations were recruited to the 
nasal turbinates following BHV-1 infection. The specificity of the fluorescent signal 
observed when dual-staining cells was confirmed by the absence of detectable 
fluorescent signal in the mucosal epithelium and lamina propria when tissue sections 
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were staining with flourochrome-conjugated isotype control monoclonal antibodies 
(Supplemental Figure 4B). Thus, co-expression analysis revealed that the predominant 
population of lymphoid cells recruited to nasal turbinates on day 5 pi were characterized 
by co-expression of CD335 and CD3 and the majority of these non-conventional T cells 
also co-expressed CD8. 
 
Figure 4.3. Immunohistochemical staining of lymphocyte subpopulations present in nasal 
turbinates following BHV-1 infection.  Sections from cryopreserved nasal turbinate were stained 
with monoclonal antibodies and an immunoperoxidase conjugate to visualize the distribution of CD335 
(a & b), CD8 (c & d) and CD3 (e & f) positive cells before (Day 0) and 5 days (Day 5) after BHV-1 
infection. No specific cellular staining was observed when using an isotype-matched irrelevant 
monoclonal antibody.  Positive cells stain brown and the inset in each panel shows the detail of cellular 
staining.  Panel images were captured at 60X magnification and the inset images were captured at 100X 
magnification. ME = Mucosal Epithelium; LP = Lamina Propria; BM = Basal Membrane 
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Figure 4.4. Co-expression of CD3 and CD8 on CD335+cells present in nasal 
turbinates on day 5 after a primary BHV-1 infection. Nasal turbinate tissue was collected 
on day 5 pi and mounted on a piece of liver to maintain the morphology of the mucosal 
epithelium. Tissues samples were cryopreserved and tissue sections double stained by 
immunofluorescence.  Staining for CD335 (Panel a - stained green) and CD8 (Panel b- red) was 
super-imposed to identify CD335+CD8+ cells (Panel c- yellow). Staining for CD335 (Panel d - 
stained green) and CD3 (Panel e- red) was super-imposed to identify CD335 cells co-expressing 
CD3 (Panel f- yellow). The liver portion of the cryosections is indicated (LIVER) and a white 
dashed line demarcates the separation between liver and nasal turbinate. DAPI was used as a 
counterstain to identify cell nuclei. Cell frequency data was generated through morphometric 
analyses. A minimum of 100 CD335+, CD3+ and CD8+cells were counted per animal and tissue 
samples from three animals were used to analyze the frequency of CD335+CD3+, CD335+CD8+ 
and CD3+CD8+ cells. Each dot represents the % cells of co-expressing the surface molecules 
indicated on the y-axis/per image/animal. ME = Mucosal Epithelium, LP = Lamina Propria. The 
images were captured at 63X magnification. 
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4.4.4.  Chemokine Induction Following BHV-1 Infection 
 
Human and mouse NKT cells express many different chemokine receptors that 
are involved in the recruitment and localization of NKT cells at sites of inflammation 
[162]. Chemokine receptor expression has not been characterized for bovine NKT cells 
but the production of IFN-γ by human NKT has been shown to provide a positive 
feedback mechanism that enhances further NKT cell recruitment through induction of 
chemokines [246]. Peak IFN-γ production following BHV-1 infection occurs on day 5 pi 
and this coincides with maximum recruitment of non-conventional T-cells (Figure 4.2). 
Therefore, we designed and validated qRT-PCR primers for known bovine chemokine 
genes (Table 4.2) to investigate whether BHV-1 infection altered the expression of 
chemokines that may be involved in recruitment of non-conventional T-cells.   Among 
the 10 bovine chemokine genes analyzed, transcript levels for CCL4 (Figure 4.5a; P < 
0.05), CCL5 (Figure 4.5b; P < 0.05) and CXCL9 (Figure 4.5c; P < 0.01) were 
significantly up-regulated on Day 7 pi. Thus, there did not appear to be a close temporal 
association between initial non-conventional T-cell recruitment to nasal turbinates and 
the onset of tissue expression of chemokine genes known to be involved in NKT cell 
recruitment.  
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Figure 4.5. Expression of chemokines in nasal turbinate tissue following primary 
BHV-1 infection.  Nasal turbinate samples were collected (n = 6 animals/time point) prior to 
and following BHV-1 infection and RNA extracted for qRT-PCR analysis abundance of CCL4 
(a), CCL5 (b), CXCL9 (c) gene transcript abundance. Gene expression was calculated as the 
change in threshold cycle (ΔCq) relative to β-actin and data presented are values for individual 
animals. The horizontal bar represents the mean value for animals sampled at each time 
sampled. A Mann-Whitney test was used to compare values relative to pre-infection (Day 0) 
levels. Significant changes in gene expression relative to Day 0 are indicated: P < 0.0332 (*), P 
≤ 0.0021 (**), P ≤ 0.0002 (***), P ≤ 0.0001 (****) 
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4.5. Discussion 
 
CD335 (NKp46, NCR1) is commonly used to identify NK cells in cattle and 
other mammalian species such as sheep [160] pigs [159], humans [247] and mice [236]. 
However, non-conventional T-cell subsets co-expressing CD335 have been reported in 
the blood, spleen, lungs and other tissues of both healthy and infected animals [157, 159, 
248]. The current study provides the first demonstration that non-conventional T cells co-
expressing both CD335 and CD8 are the predominant lymphocyte population recruited to 
the URT following a primary BHV-1 infection. The frequency of CD335+CD3+ T- cells 
in bovine blood ranges between 0.1 to 1.7 % of blood mononuclear cells and CD3+ cells 
usually comprise less than 10% of all CD335+ lymphocytes in blood [157]. The 
frequency of CD335+ T-cells recruited to the URT following a primary BHV-1 infection 
was 77.5% of all CD335+ lymphocytes (Figure 4.4h) and 78.5% of all T cells (Figure 
4.4i). This observation supports the conclusion that there was a highly selective 
recruitment of these non-conventional T-cells. Recruitment of CD335+ T cells to the 
lung of pigs was also reported following influenza infection [159],  suggesting that 
CD335+ T cells may play an important role in the control of respiratory viral infections. 
Non-MHC restricted cytotoxic cells were previously reported to be recruited to the lungs 
of calves following a primary BHV-1 infection but the phenotype of these cells was not 
determined [192]. Thus, further phenotypic and functional analysis of immune cells 
recruited during primary viral infections may reveal that non-conventional T cells 
provide an important early response to infection.  
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The majority of non-conventional T-cells recruited to the URT also co-expressed 
CD8 (Figure 4.4g) and bovine CD335+CD8+ T-cells were shown to produce IFN-γ when 
stimulated through CD3 [157]. Recruitment of primarily CD8+ non-conventional T cells 
to the URT is consistent with the previous observation that 75% of non-conventional T 
cells in blood co-express CD8 [157]. Maximum recruitment of non-conventional T cells 
to the nasal turbinates was observed on day 5 post-BHV-1 infection which coincides with 
maximum IFN-γ secretion in nasal secretions [230]. The IHC staining of nasal turbinates 
for IFN-γ revealed, however, a diffuse staining pattern that could not be localized to cells 
located in either the mucosal epithelium or submucosa (Figure 4.1d). Thus, it was not 
possible to directly link increased IFN-γ production following BHV-1 infection with the 
recruitment of a large number of non-conventional T cells. Future studies will be 
necessary to develop methods to isolate this unique T cell population from tissue 
following viral infection for the analysis of IFN-γ secretion or alternatively perform in 
situ analysis of IFN-γ transcript within individual cells co-expressing CD335 and CD3. It 
would also be interesting to determine if IFN-α is a potent activator of IFN-γ secretion by 
bovine non-conventional T cells since peak production of both types of IFN occur on day 
5 post-BHV-1 infection [230]. 
 
Innate and acquired immune responses to BHV-1 infection have been an area of 
research interest for over 40 years [249], and a variety of cell-mediated cytotoxic 
mechanisms have been implicated as important for the control and clearance of a primary  
BHV-1 infection  [71, 82, 192]. IFN-γ secretion has also been frequently used as an 
indicator of either NK cell or T-cell activation by BHV-1 proteins but these studies were 
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frequently performed with lymphocytes isolated from blood [113].  This is the first report 
that identifies effector lymphocyte populations recruited to mucosal surface of the URT 
following a primary BHV-1 infection. In this study, we combined IHC and IF analyses to 
demonstrate that CD8+ non-conventional T cells were the primary lymphocyte population 
recruited early during a primary BHV-1 infection. Significant (P < 0.05) recruitment of 
this non-conventional T cell population to the lamina propria was, however, limited to 
day 5 pi (Figure 2). A previous study in mice demonstrated that NK cell recruitment to 
lymph nodes following poxvirus infection was dependent on IFN-γ production [228]. 
This observation may explain the coincidence of peak non-conventional T cell 
recruitment to nasal turbinates with maximum levels of IFN-γ in nasal secretions [230]. 
An alternative explanation may be that data showing recruitment of non-conventional T 
cells was biased by sampling nasal turbinate tissues at a fixed site. BHV-1 infection in 
the URT of naïve calves occurs within discrete foci of mucosal epithelium [230]. When 
non-conventional T-cells are first recruited from blood, they may be abundant throughout 
the lamina propria but the apparent decline in number of lymphocytes throughout the 
lamina propria on days 7 and 10 pi (Figure 4.2) may reflect further recruitment and 
localization of non-conventional T- cells to foci of viral infection. IHC studies analyzing 
lymphocyte subpopulations recruited specifically to foci of BHV-1 infection in the URT 
may better define the kinetics of effector lymphocyte populations recruited during viral 
infection.   
 
Chemotactic migration of non-conventional T-cell subsets has been examined in 
mice and humans but the chemokines involved in non-conventional T-cell recruitment in 
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cattle is not known. Murine iNKT cells express CCR7, CXCR3, CXCR6, CCR4 and 
CCR6 chemokine receptors [194], of which CCR4 was critical for localization to the lung 
[195]. CXCR6, CCR1, and CCR6 are expressed on the surface of human NKT cells 
[196]. These studies indicate that non-conventional T cells express multiple chemokine 
receptors and individual receptors may be involved in tissue specific recruitment. Bovine 
CD335+CD2+ NK cells have been shown to express several chemokine receptors 
including CCR1, CCR8, CXCR6 and CX3CR1, while CD335+CD2- NK cells expressed 
CCDR2, CCR5, CCR6, CCR7, CXCR3, CXCR4 and CXCR5 [199]. Thus, bovine NK 
cells also have the capacity to respond to abroad range of chemokines. The expression of 
11 known bovine chemokine genes was analyzed in nasal turbinate tissue collected 
following BHV-1 infection and CCL4, CCL5, CXCL9 were significantly (P < 0.05) up-
regulated (Figure 4.5). Transcript abundance for all three chemokine genes was greatest 
on day 7 pi and then remained at a similar level on day 10 pi. Significant chemokine gene 
expression on day 7 pi coincided with the highest level of BHV-1 replication and 
shedding in nasal secretions [230]. If these chemokines are involved in non-conventional 
T cell recruitment to viral infected mucosal epithelial cells then the temporal pattern of 
chemokine gene expression may explain the apparent decline in these T-cell subsets’ 
abundance in the lamina propria on days 7 and 10 pi. It is also interesting that maximum 
CXCL9 gene expression occurred on day 7 pi, which is 2 days after peak IFN-γ 
production in the URT [230]. Increased expression of CXCL9, also known as Monokine 
induced by interferon gamma (MIG; Table 4.2), is consistent with the strong IFN-γ 
response observed following BHV-1 infection [230]. If CXCL9 is a chemokine involved 
in non-conventional T cell recruitment then the IFN-γ response induced during BHV-1 
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infection may play an indirect role in recruitment of this specific effector cell population. 
Further clarification of which chemokines are involved in the specific recruitment of non-
conventional T cells will require an analysis of chemokine receptor expression by these 
cells.  
 
4.6. Conclusion 
 
The present study demonstrates that CD335+CD8+ non-conventional T-cells are the 
predominant lymphocyte population recruited to the lamina propria of nasal turbinates 
within 5 days after a primary BHV-1 infection. Dual-colour IF studies confirmed that 
over 75% of both CD335+ cells and CD3+ cells present in the lamina propria on day 5 pi 
could be classified as non-conventional T-cells. Although bovine CD335+CD8+ cells are 
a minor lymphoid population in blood [157], over 30 CD335+CD8+ T-cells/0.196 mm2 
were present in bovine nasal turbinate tissue on day 5 pi. This represents a highly specific 
recruitment of non-conventional T-cells and suggests that CD335+CD8+ T-cells may be 
an important effector population for the control or clearance of a herpesvirus infection. 
The recruitment of these non-conventional T-cells was associated with increased 
expression of three different chemokines, indicating that this tissue-specific recruitment 
may involve multiple chemoattractant signals. Finally, the T cell receptor repertoire of 
these cells needs to be determined before classifying these cells as either innate or 
adaptive T cells. 
 
 !
! 116!
Acknowledgements 
This research was funded by the Saskatchewan Agriculture Development Fund (ADF) 
and the Natural Sciences and Engineering Research Council of Canada (NSERC). Rahwa 
Osman was supported by a Vaccinology & Immunotherapeutics Program, University of 
Saskatchewan Graduate Scholarship and Natural Sciences and Engineering Research 
Council : Collaborative Research and Training Experience (NSERC-CREATE) program, 
Dr. Philip Griebel is funded by a Tier I Canada Research Chair (CRC) in Neonatal 
Mucosal Immunology provided by Canada Institutes for Health Research (CIHR). We 
would like to thank Nathalie Berube and Dr. Patricia Gonzalez-Cano for their technical 
assistance with confocal imaging and primer design and validation, respectively. We also 
acknowledge the excellent technical assistance provided by Dr. Don Wilson, Brock 
Evans, and the staff of Prairie Diagnostics Services, Saskatoon, SK when collecting 
samples from animals. This manuscript is published with permission of the Director of 
VIDO-Intervac as journal series # 814. 
 !!!!!!!!!!
%
%
%
117!!
4.7. Supplemental Figures 
%
Supplemental Figure 4A. Nasal turbinates in the upper respiratory tract of a 6 
month old calf. A midsagittal cross-section of the head shows nasal turbinates located 
posterior to the external nares and photograph was taken on day 5 post-BHV-1 infection. 
Nasal turbinate samples were collected at the location indicated by the dashed lines on 
Days 0 (pre-infection) Day 3, 5, 7 and 10 post-infection. Tissue samples were collected 
from 6 calves at each time point. N T = Nasal turbinates%
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Supplemental Figure 4B. IgG1 Isotype Control staining of nasal turbinate tissue 
section on day 5 post primary BHV-1 infection. Nasal turbinate tissue was collected on 
day 5 pi. Tissues sections were stained with an equivalent concentration of IgG1 isotype 
control directly conjugated to Alexa Fluor® 594 (Red fluorescence) and was used as a 
specificity control when dual-staining for CD335 versus CD3 and CD335 versus CD8 
(Figure 4.4). DAPI was used as a counterstain to identify cell nuclei. ME = Mucosal 
Epithelium, LP = Lamina Propria. Images were captured at 63X magnification. 
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CHAPTER 5. GENERAL DISCUSSION ! Over!60!years!of!BHV81!research!has!provided!a!wealth!of!information!regarding!the!structure!and!biology!of!this!virus.!!The!BHV81!genome!has!been!sequenced!and!numerous!studies!have!characterized!the!biology!and!function!of!individual!viral!proteins!and!their!potential!use!as!vaccine!candidates![250].!!Several!generations!of!BHV81!vaccines!ranging!from!killed!to!modified8live!and!parenteral!to!mucosal!vaccines!have!been!formulated!since!the!first!BHV81!vaccine!was!available!in!1957![251].!However,!there!is!still!limited!information!regarding!the!host!immune!defense!mechanisms!that!play!a!critical!role!in!the!control!and!clearance!of!a!primary!BHV81!infection.!!Previous!investigations!documented!high!IFN8α!and!8γ production!during!primary!BHV81!infections,!which!suggested!that!IFNs!may!play!an!important!role!in!the!control!of!BHV81!infection![67].!However,!these!studies!also!reported!that!high!interferon!levels!coincided!with!shedding!of!over!106pfu/ml!in!nasal!secretion![67].!!Our!animal!studies!confirmed!that!BHV81!is!a!potent!inducer!of!both!type!I!and!II!interferons!but!in'vitro'studies!demonstrated!that!BHV81!replication!was!limited!by!less!than!50%!following!the!induction!of!antiviral!effector!mechanisms!by!both!recombinant!bovine!IFN8α!and!8γ.!These!observations!raised!further!questions!regarding!the!role!of!IFNs!in!limiting!BHV81!infection.!!!
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I!extended!the!analysis!of!Type!I!IFNs!to!include!both!the!expression!of!IFN8β!in'vivo'and!the!antiviral!activity!of!IFN8β!in'vitro.!These!analyses!confirmed!that!IFN8β!expression!is!increased!early!during!a!primary!BHV81!infection!and!IFN8β!has!a!greater!capacity!than!either!IFN8α!or!–γ!to!directly!inhibit!BHV81!replication.!Thus,!IFN8β!may!be!important!in!controlling!the!magnitude!of!BHV81!replication!during!a!primary!respiratory!infection.!However,!during!a!BHV81!infection'in'vivo,!the!early!induction!of!IFN8β!was!not!associated!with!a!rapid!decline!in!virus!replication!and!virus!shedding!continued!to!increase!in!the!face!of!significant!up8regulation!of!IFN8β!gene!expression!in!nasal!turbinates!and IFN-β secretion in the nasal cavity.!The!question!remains,!however,!whether!the!multifaceted!IFN!response!plays an 
important role in the indirect activation of either innate or adaptive defences against 
BHV-1 infection.  
 
It is interesting to note that the current transcriptional and IHC studies indicate that both 
type I and II IFNs were expressed in nasal turbinates prior to BHV-1 infection. This 
observation contradicts the common belief that IFNs are induced only after a viral 
infection. One possible explanation for this phenomenon may be that IFNs are 
constitutively expressed at a relatively low level in healthy calves, as has been reported 
for swine [252]. Alternatively, other environmental factors, such as the respiratory 
virome, may act as an inducer of IFN production since animals were not housed in an 
isolation unit prior to BHV-1 challenge. The presence of varying stimuli within 
individual animals would be consistent with the highly variable level of type I and II IFN 
gene expression observed among animals prior to BHV-1 infections (Figure 3.3). 
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Background IFN activity may also explain why a relatively high dose of BHV-1 was 
used in the current animal studies to ensure that all animals became infected, showed 
clinical diseases and shed virus in nasal secretions (Figure 3.1).   
 
Although IFN gene expression and IFN secretion increased significantly (P < 0.05) 
within three days after the infection (Figure 3.3) virus replication and shedding persisted 
for 10 days pi. Recombinant bovine IFNs have been reported to induce many of the 
clinical symptoms associated with BHV-1 infection, including fever, loss of appetite, 
diarrhea, and weight loss [55].  Therefore, it is not apparent that the multifaceted!IFN!is!
beneficial to the host. Concurrent production of IFN-α, -β and −γ following BHV-1 
infection also appears redundant when comparing the anti-viral effector genes induced by 
both type I and II IFNs (Figure 3.6).  Although the potential benefit of a redundant IFN- 
response has not been studies in cattle, Zanotti et al have shown that porcine IFN-aFN-in-
b subtypes vary in their capacity to induce antiviral, inflammatory and immune 
modulation effects and this redundancy contributes to host protection [253]. !
 My current studies indicate that despite gene expression and secretion of multiple IFN 
types and sustained induction of antiviral effector genes in viral infected tissues, there 
was limited control of BHV-1 replication and shedding. The importance of individual 
IFNs during viral infections has been studied using a variety of animal models or natural 
gene defects that disrupt IFN genes or IFN receptors [254, 255]. These tools are not 
available in cattle at this time so I can only speculate to what extent IFNs play a critical 
role in controlling a primary BHV-1 infection. It may be logical to assume that in the 
! 122!
complete absence of either type I or type II IFN, the level of BHV-1 infection and 
shedding would be much greater than observed in the current study. !
An alternate explanation for abundant IFN-γ secretion during the peak of BHV-1 
replication [230] may be that IFN-γ production reflects the recruitment of activated NK-
cells or cytotoxic T lymphocytes to the site of viral infection.  One way to test this 
hypothesis was to analyze the phenotype of lymphocytes recruited to the URT during 
BHV-1 infection.  IHC studies revealed that both CD8+ and CD335+ cells were recruited 
to BHV-1 infected nasal turbinates. The kinetics of cell recruitment over the 10 days of 
BHV-1 infection varied between tissues, such that peak recruitment of CD3+, CD8+ and 
CD335+ cells occurred in nasal turbinates on day 5 pi. In contrast, no significant 
recruitment of these lymphocytes was detected in the trachea following BHV-1 infection 
(APPENDIX A). These observations suggest that lymphocyte recruitment following 
BHV-1 infection may be tissue-specific even though BHV-1 infection was confirmed in 
both tissues [230]. Furthermore, the recruitment of CD3+ and CD335+ cells in the URT 
coincided with peak IFN-γ levels in nasal secretions.  !
The phenotype analysis of lymphocytes present in nasal turbinates following BHV-1 
infection revealed that peak IFN-γ levels coincided with peak recruitment of a non-
conventional T-cell population (Figure 3.3 and Figure 4.4).  We were unable to directly 
link increased IFN-γ production to non-conventional T cells recruitment on day 5 pi due 
to diffuse staining of IFN-γ. Future studies could possibly use in situ analysis of IFN 
transcripts to localize IFN gene expression to individual cells as has been done in other 
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studies [256]. Another alternative approach to determine if non-conventional T cells are 
the primary source of IFN-γ secreted in nasal secretions may be to develop tissue 
digestion methods to isolate single cell suspensions from the lamina propria and 
epithelium of nasal turbinates and trachea following BHV-1 infection. If sufficient viable 
lymphocyte numbers could be recovered from digested tissues then multi-color 
immunofluorescence could be used to co-stain for lymphocyte surface markers, 
intracellular IFN-γ, and other lymphocyte activation markers. These analyses would 
provide further evidence regarding the functional state of this unique T cell 
subpopulation following their recruitment to a mucosal site of viral infection. !
The phenotype of lymphocytes recruited following BHV-1 infection was further clarified 
by dual-staining to analyze the expression of the CD8 cytotoxic lymphocyte marker on 
both CD335+ and CD3+ lymphocytes. This IF analysis revealed that the majority of 
lymphocytes recruited to nasal turbinates following BHV-1 infection were non-
conventional CD3+ T-cells that expressed both CD335 and CD8. It is currently not 
known whether these non-conventional T cells represent an innate or adaptive immune 
response. Further characterization of the T-cell repertoire of this recruited population is 
required before this distinction can be made. A limited TcR repertoire has been observed 
for iNKT cells [257]. iNKT cells express a TCR with an invariant chain which limits 
their antigen recognition repertoire and iNKT cells recognize lipid ligands presented in 
the context of the non-MHC surface molecule, CD1d. MAIT cells also express a semi-
variant TCR which limits their T-cell repertoire relative to conventional T-cells. These 
cells recognize antigens in the context of the non-classical-MHC molecule, MR1 [163] 
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and bind vitamin B metabolite ligands [242]. While MAIT cells have been characterized 
in humans [240] and mice [163], there currently is no evidence for an equivalent 
population in cattle. Further analysis of TcR expression by bovine non-conventional T-
cells is required to determine if these cells are analogous to either NKT [257] or MAIT 
cells [241] and should be classified as part of the innate or adaptive immune response to 
BHV-1 infection. !
Although my IHC studies established a temporal association between recruitment of non-
conventional T-cells and subsequent clearance of BHV-1 infection, further studies are 
required to determine whether CD335+ T cells can function as effector cells able to 
eliminate BHV-1 infected cells. Based on the cytotoxic response mediated by bovine 
CD335+CD3+ cells during a parasitic infection, it is likely that these cells have the 
capacity to lyse BHV-1 infected cells [157]. Further IHC studies may be useful in 
demonstrating that the CD335+ T cells migrate from the lamina propria and localize at 
foci of BHV-1 infected mucosal epithelial cells. Furthermore, CD335+ T cells isolated 
from either blood or nasal turbinates, following BHV-1 infection, could be tested in in 
vitro assays to determine whether these non-conventional T cells display either MHC-
restricted or non-MHC restricted cytotoxicity with BHV-1 infected cells. Bovine non-
conventional T-cells have been shown to be activated through both CD335 and CD3 and 
have the potential to mediate both MHC-restricted and non-MHC-restricted cytotoxicity 
[157].  These studies may provide further evidence that non-conventional T cells are an 
important effector population for the control and clearance of a primary BHV-1 
respiratory infection.  IF results indicate, however, that not all CD3+ lymphocytes present 
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in nasal turbinates during BHV-1 are CD335+ (Figure 4.4i). Therefore, further analysis 
may be warranted to determine whether other T-cell subsets, such as γδT-cells, may also 
contribute to the control and clearance of a primary BHV-1 infection. 
 
Differences in lymphocyte recruitment to nasal turbinates and trachea may reflect 
differences in the kinetics or magnitude of viral infection in these tissues. These 
differences in viral infection may then result in differences in the expression of tissue-
specific adhesion molecules or chemokines required for cell recruitment.  We observed a 
different combination of chemokine genes were significantly (P < 0.05) up-regulated in 
nasal turbinates and trachea following BHV-1 infection (APPENDIX B).  CXCL-8, 
CCL2, CCL3, and CCL4 genes were upregulated in trachea. In contrast. CCL4, CCL5 
and CXCL9 gene expression was significantly (P < 0.05) increased in nasal turbinates. 
Further information regarding the specific chemokines involved in the specific 
recruitment of non-conventional T cells is necessary before it can be concluded that 
differential chemokine production played a role in determining the differential cell 
recruitment observed in these two tissues.   !
Morphometric analyses revealed a recruitment pattern for CD335+ and CD8+ 
lymphocytes that was very brief with a significant (P < 0.05) increase in these cells in the 
lamina propria of nasal turbinates only on Day 5 pi (Figure 4.2).  This temporal 
regulation of lymphocyte recruitment may reflect chemokine and adhesion molecule 
expression in this tissue but this conclusion is not consistent with the observed pattern of 
chemokine gene expression in nasal turbinates (Figure 4.5). Alternatively, morphometric 
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data may reflect the limitations associated with sampling tissues at a fixed site (10-12 
mm into the external nares) throughout the course of viral infection and analyzing 
lymphocyte numbers in the lamina propria compartment. The lamina propria of nasal 
turbinates is highly vascular and likely to function as an important site for lymphocyte 
recruitment from blood. Further lymphocyte migration to foci of BHV-1 infected 
mucosal epithelial cells (Figure 3.2) would, however, create a dynamic balance between 
recruitment from blood and localization at sites of viral infection. Morphometric analyses 
of lymphocyte numbers in the lamina propria was predicated on the random distribution 
of lymphocytes. A more accurate representation of lymphocyte recruitment may have 
been achieved by selecting only those tissue sections that included both the lamina 
propria and a foci of BHV-1 infection. This may have provided a more complete analysis 
of both lymphocyte recruitment and localization to the site of BHV-1 infection.  
 
Non-conventional T-cells have been characterized in bovine blood [157], porcine lungs 
[159] and humans [161]. The current study is the first demonstration that non-
conventional T-cells can be recruited to a mucosal site following a viral infection in the 
URT.   To further understand recruitment of this unique effector cell population we 
analyzed chemokine gene expression following BHV-1 infection. The expression of 
CCL4, CCL5 and CXCL9 genes were significantly (P < 0.0332) up-regulated in nasal 
turbinates following BHV-1 infection.  This observation suggested that multiple 
chemokines may be involved in the specific recruitment of non-conventional T-cells.  
However, maximum chemokine expression did not coincide with the observed peak in 
non-conventional T-cell recruitment to the lamina propria.  As discussed previously, the 
failure to correlate chemokine gene expression with lymphocyte recruitment may reflect 
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limitations of the current morphometric analysis methodology.  In a recent study, 
Mycobacterium bovis-infected DCs selectively recruited NKp46+CD2- cells following 
transcriptional upregulation of the CCL3, CCL4, CCL5, CCL20 and CXCL8 chemokine 
genes [199]. An alternative explanation for the lack of correlation between chemokine 
gene expression and non-conventional T cell recruitment may be that chemokine genes, 
other than those analyzed in this study, may be involved in recruitment of this unique T 
cell subpopulation. Chemotaxis studies with recombinant chemokine proteins may 
further clarify the capacity of non-conventional T cells to respond to the specific 
chemokines expressed in BHV-1 infected tissues. Alternatively, an analysis of 
chemokine receptor gene expression by non-conventional T cells purified from bovine 
blood may provide insight into which chemokine genes should be analyzed following 
BHV-1 infection. 
 
In conclusion, my in vivo findings demonstrated that IFNs have limited capacity 
to control a primary BHV-1 infection despite early induction of a multifaceted type I and 
II IFN response and ISG expression.  In contrast, recruitment of CD335+CD8+ T-cells 
within 5 days pi may provide an important host response contributing to the control of a 
primary BHV-1 infection. These non-conventional T cells were the major effector 
population recruited to nasal turbinates during a BHV-1 respiratory infection but it 
remains to be confirmed that CD335+CD8+T-cells have the capacity to lyse BHV-1 
infected epithelial cells.  Future studies are also needed to further characterize the TcR 
repertoire of CD335+CD8+T-cells before it can be concluded whether they constitute part 
of the innate or adaptive immune response to BHV-1 infection. If CD335+CD8+T-cells 
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are innate immune cells, then early recruitment of non-conventional T-cells following a 
primary viral infection may enable the host to recognize viral infected cells through 
NKp46. Alternatively, if these non-conventional T cells are part of the adaptive immune 
response then they may confer immune memory following a primary BHV-1 infection. If 
these cells are found to be adaptive and cytotoxic, then the specific induction of this 
unique T cell subpopulation may provide a surrogate measure for evaluating future BHV-
1 vaccines that induce an improved cell-mediated immune response. It would then be 
necessary to investigate CD335+CD8+T-cell recognition of individual BHV-1 proteins 
and determine whether BHV-1 vaccination could increase the frequency of this relatively 
rare T-cell subpopulation [157].  !!!!!!!!!!!!!!!!!!!!!!!!!!
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APPENDICES !
5.1 APPENDIX A: Lymphocyte recruitment to Bovine Trachea post-BHV-1 infection  !
!!!
APPENDIX A Figure 1. Frequency of lymphoid subpopulations present in trachea 
following a primary BHV-1 infection. Immunohistochemical staining was performed 
with monoclonal antibodies to identify CD335+ (a) CD8+ (b) CD4+ (c) and CD3+ cells 
(d). Morphometric analyses were used to quantify the frequency of each cell type located 
within the tracheal intraepithelial and submucosal compartments. Data presented are the 
mean and standard error of the mean for values from tissues sections analyzed from 6 
animals/time point following BHV-1 infection. One-way ANOVA was used to compare 
values relative to pre-infection (Day 0) levels and significant changes in frequency of 
leukocytes relative to Day 0 are indicated as  P < 0.05 (*), P ≤ 0.01 (**), P ≤ 0.001 
(***),   P ≤ 0.0001 (****). !!
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5.2 APPENDIX B:!Chemokine expression in bovine trachea post-BHV-1 infection!!
!
APPENDIX B Figure 1. Expression of chemokines in tracheal tissue following primary 
BHV-1 infection.  Tracheal tissue samples were collected (n = 6 animals/time point) prior to 
and following BHV-1 infection and RNA extracted for qRT-PCR analysis abundance of IL-
8(a), CCL2 (b), CCL3 (c) and CCL4(d) and IL-10 (e) gene transcript abundance. Gene 
expression was calculated as the change in threshold cycle (ΔCq) relative to β-actin and data 
presented are values for individual animals. The horizontal bar represents the mean value for 
animals sampled at each time sampled. A Mann-Whitney test was used to compare values 
relative to pre-infection (Day 0) levels. Significant changes in gene expression relative to Day 0 
are indicated: P < 0.0332 (*), P ≤ 0.0021 (**), P ≤ 0.0002 (***), P ≤ 0.0001 (****). 
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